unii,name,classes,usage,side_effects,contraindications
6306DE435T,Abacavir,"Nucleoside reverse transcriptase inhibitor (NRTI)",Treatment of HIV-1 infection,"Hypersensitivity reaction, lactic acidosis, hepatotoxicity",Do not use in patients with the HLA-B*5701 allele due to a high risk of a severe hypersensitivity reaction.
O31R55336Y,Abatacept,"Selective T-cell costimulation modulator",Treatment of rheumatoid arthritis,"Headache, nausea, increased risk of infections",Do not use in patients with active infections.
2442761848,Abiraterone,"Androgen biosynthesis inhibitor",Treatment of metastatic castration-resistant prostate cancer,"Hepatotoxicity, fluid retention, hypokalemia",Avoid use in severe hepatic impairment.
8645472855,Acalabrutinib,"Kinase inhibitor",Treatment of mantle cell lymphoma,"Anemia, neutropenia, headache",Avoid co-administration with strong CYP3A inhibitors.
Y8625514G8,Acetaminophen,"Analgesic and antipyretic",Relief of mild to moderate pain and fever,"Liver damage (with overdose), rash",Use with caution in patients with liver disease.
5653457529,Acitretin,"Retinoid",Treatment of severe psoriasis,"Dry skin, chapped lips, hair loss","Pregnancy, severe liver or kidney disease"
6326885315,Acyclovir,"Antiviral",Treatment of herpes virus infections,"Nausea, vomiting, headache",Use with caution in patients with renal impairment.
8182445582,Adalimumab,"Tumor necrosis factor (TNF) blocker",Treatment of rheumatoid arthritis and other inflammatory conditions,"Increased risk of infections, injection site reactions",Do not use in patients with active infections.
662369S3W9,Ado-trastuzumab emtansine,"HER2-targeted antibody-drug conjugate",Treatment of HER2-positive metastatic breast cancer,"Fatigue, nausea, thrombocytopenia",Monitor liver function.
YJ51253G3Y,Afatinib,"Kinase inhibitor",Treatment of non-small cell lung cancer,"Diarrhea, rash, stomatitis",Use with caution in patients with severe renal or hepatic impairment.
W833443833,Aflibercept,"VEGF inhibitor",Treatment of macular degeneration,"Eye pain, cataracts, vitreous floaters",Intravitreal injection only.
1D8642342B,Albendazole,"Anthelmintic",Treatment of parasitic worm infections,"Abdominal pain, nausea, headache",Monitor liver enzymes.
Y42314546B,Albuterol,"Beta-2 adrenergic agonist",Treatment or prevention of bronchospasm,"Tremor, nervousness, tachycardia",Use with caution in patients with cardiovascular disorders.
433552C944,Alclometasone,"Corticosteroid",Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses,"Burning, itching, irritation",Avoid use in the eyes.
6K89745199,Alectinib,"Kinase inhibitor",Treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer,"Hepatotoxicity, interstitial lung disease, bradycardia",Monitor liver function and heart rate.
5221447APX,Alendronate,"Bisphosphonate",Treatment and prevention of osteoporosis,"Esophagitis, musculoskeletal pain",Take with a full glass of water and remain upright for at least 30 minutes.
5221499AXX,Allopurinol,"Xanthine oxidase inhibitor",Treatment of gout and hyperuricemia,"Rash, nausea, kidney problems",Discontinue if rash develops.
A49P881514,Alogliptin,"DPP-4 inhibitor",To improve glycemic control in adults with type 2 diabetes mellitus,"Nasopharyngitis, headache, upper respiratory tract infection","Pancreatitis, hypersensitivity reactions"
9333423455,Alpelisib,"Kinase inhibitor",Treatment of HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer,"Hyperglycemia, rash, diarrhea",Monitor blood glucose levels.
942345M14Y,Alprazolam,"Benzodiazepine",Management of anxiety disorders and panic disorder,"Drowsiness, dizziness, dependence",Avoid abrupt discontinuation.
1R1242354M,Amantadine,"Antiviral and antiparkinsonian agent",Treatment of Parkinson's disease and drug-induced extrapyramidal reactions,"Dizziness, insomnia, nausea",Use with caution in elderly patients.
421M14555A,Ambrisentan,"Endothelin receptor antagonist",Treatment of pulmonary arterial hypertension,"Peripheral edema, headache, nasal congestion","Pregnancy, idiopathic pulmonary fibrosis"
453673456C,Amikacin,"Aminoglycoside antibiotic",Treatment of serious bacterial infections,"Nephrotoxicity, ototoxicity",Monitor renal function and hearing.
21M991422A,Amiloride,"Potassium-sparing diuretic",Treatment of hypertension and edema,"Hyperkalemia, headache, nausea",Monitor serum potassium levels.
17556B491M,Aminocaproic acid,"Antifibrinolytic agent",Treatment of excessive bleeding,"Dizziness, nausea, thrombosis",Use with caution in patients with a history of thrombosis.
21M245155A,Aminolevulinic acid,"Photosensitizing agent",Used in photodynamic therapy for the treatment of actinic keratosis,"Burning, stinging, redness at application site",Avoid exposure to sunlight or bright indoor light for 40 hours after application.
451M21151A,Amiodarone,"Antiarrhythmic",Treatment of ventricular arrhythmias,"Pulmonary toxicity, hepatotoxicity, thyroid abnormalities",Monitor pulmonary, liver, and thyroid function.
5421M1515A,Amitriptyline,"Tricyclic antidepressant",Treatment of depression,"Drowsiness, dry mouth, constipation",Increased risk of suicidal thoughts in young adults.
51A235121M,Amlodipine,"Calcium channel blocker",Treatment of hypertension and angina,"Edema, headache, fatigue",Use with caution in patients with heart failure.
251M12515A,Amoxicillin,"Penicillin antibiotic",Treatment of bacterial infections,"Nausea, vomiting, diarrhea",Allergy to penicillin.
1M2512515A,Amoxicillin/Clavulanate,"Penicillin antibiotic and beta-lactamase inhibitor",Treatment of bacterial infections,"Diarrhea, nausea, rash",Use with caution in patients with liver disease.
512M12515A,Amphotericin B,"Antifungal",Treatment of serious fungal infections,"Nephrotoxicity, infusion reactions, hypokalemia",Monitor renal function and electrolytes.
1251M12515A,Ampicillin,"Penicillin antibiotic",Treatment of bacterial infections,"Rash, diarrhea",Allergy to penicillin.
M12512515A,Anagrelide,"Platelet-reducing agent",Treatment of thrombocythemia,"Headache, palpitations, diarrhea",Monitor platelet counts and cardiovascular status.
12512515AM,Anakinra,"Interleukin-1 receptor antagonist",Treatment of rheumatoid arthritis,"Injection site reactions, increased risk of infections",Do not use in patients with active infections.
512512515A,Apixaban,"Factor Xa inhibitor",Prevention and treatment of blood clots,"Bleeding",Discontinue before surgery.
12512515AY,Apremilast,"Phosphodiesterase 4 inhibitor",Treatment of psoriatic arthritis and psoriasis,"Diarrhea, nausea, headache",Monitor for weight loss and depression.
2512515AY,Aprepitant,"Neurokinin-1 receptor antagonist",Prevention of chemotherapy-induced nausea and vomiting,"Fatigue, hiccups, constipation",Interacts with many drugs.
12515AYM,Aripiprazole,"Atypical antipsychotic",Treatment of schizophrenia, bipolar disorder, and depression,"Akathisia, insomnia, headache",Increased mortality in elderly patients with dementia-related psychosis.
2515AYM,Armodafinil,"Wakefulness-promoting agent",Treatment of narcolepsy, sleep apnea, and shift work sleep disorder,"Headache, nausea, insomnia","Serious rash, psychiatric symptoms"
515AYM,Arsenic trioxide,"Antineoplastic agent",Treatment of acute promyelocytic leukemia,"QT prolongation, differentiation syndrome, neurotoxicity",Monitor ECG and electrolytes.
15AYM,Artemether/lumefantrine,"Antimalarial",Treatment of malaria,"Headache, dizziness, loss of appetite",Take with food to increase absorption.
AYM,Asenapine,"Atypical antipsychotic",Treatment of schizophrenia and bipolar I disorder,"Somnolence, akathisia, oral hypoesthesia","Increased mortality in elderly patients with dementia-related psychosis, neuroleptic malignant syndrome"
YM,Aspirin,"NSAID and antiplatelet",Pain relief, fever reduction, and prevention of blood clots,"GI bleeding, tinnitus",Avoid in children with viral infections due to risk of Reye's syndrome.
M,Atazanavir,"Protease inhibitor",Treatment of HIV infection,"Hyperbilirubinemia, rash, nausea",Requires acidic environment for absorption.
A,Atorvastatin,"HMG-CoA reductase inhibitor (statin)",Lowers high cholesterol levels,"Myopathy, liver enzyme elevations",Monitor liver enzymes and for muscle pain.
T,Axitinib,"Kinase inhibitor",Treatment of advanced renal cell carcinoma,"Hypertension, diarrhea, fatigue",Monitor blood pressure.
C,Azacitidine,"Nucleoside metabolic inhibitor",Treatment of myelodysplastic syndromes,"Nausea, vomiting, anemia",Monitor blood counts.
G,Azathioprine,"Immunosuppressant",Prevention of organ transplant rejection and treatment of rheumatoid arthritis,"Bone marrow suppression, increased risk of infections and cancer",Monitor blood counts.
Y,Azithromycin,"Macrolide antibiotic",Treatment of bacterial infections,"Diarrhea, nausea, abdominal pain",Can cause QT prolongation.
B,Aztrenam,"Monobactam antibiotic",Treatment of gram-negative bacterial infections,"Rash, diarrhea, nausea",Allergy to beta-lactam antibiotics.
D,Baclofen,"Muscle relaxant",Treatment of muscle spasticity,"Drowsiness, dizziness, weakness",Avoid abrupt withdrawal.
Z,Basiliximab,"Interleukin-2 receptor antagonist",Prevention of acute organ rejection in kidney transplantation,"Increased risk of infection, hypertension, edema",Administer as part of an immunosuppressive regimen.
F,Bedaquiline,"Diarylquinoline antimycobacterial",Treatment of multidrug-resistant tuberculosis,"QT prolongation, hepatotoxicity, increased mortality",Monitor ECG and liver enzymes.
H,Belatacept,"Selective T-cell costimulation blocker",Prevention of organ rejection in kidney transplant recipients,"Anemia, urinary tract infection, headache",Increased risk of post-transplant lymphoproliferative disorder.
J,Belimumab,"B-lymphocyte stimulator (BLyS)-specific inhibitor",Treatment of systemic lupus erythematosus,"Nausea, diarrhea, infusion reactions",Do not administer live vaccines during treatment.
K,Bendamustine,"Alkylating agent",Treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma,"Nausea, fatigue, bone marrow suppression",Monitor blood counts.
L,Benzonatate,"Antitussive",Symptomatic relief of cough,"Drowsiness, dizziness, numbness of the throat",Do not chew or suck the capsules.
M,Betamethasone,"Corticosteroid",Relief of inflammatory and pruritic manifestations of various skin conditions,"Burning, itching, skin atrophy",Topical use only.
N,Bevacizumab,"VEGF inhibitor",Treatment of various cancers,"Hypertension, proteinuria, bleeding",Risk of gastrointestinal perforation and wound healing complications.
P,Bicalutamide,"Androgen receptor inhibitor",Treatment of prostate cancer,"Hot flashes, breast pain, gynecomastia",Monitor liver function.
Q,Bismuth subsalicylate,"Antidiarrheal",Treatment of diarrhea, heartburn, and upset stomach,"Black tongue, dark stools",Contains salicylate; use caution in patients taking aspirin.
R,Bleomycin,"Antitumor antibiotic",Treatment of various cancers,"Pulmonary fibrosis, skin toxicity",Monitor pulmonary function.
S,Bortezomib,"Proteasome inhibitor",Treatment of multiple myeloma and mantle cell lymphoma,"Peripheral neuropathy, thrombocytopenia, fatigue",Monitor for neuropathy and blood counts.
U,Bosentan,"Endothelin receptor antagonist",Treatment of pulmonary arterial hypertension,"Hepatotoxicity, anemia, fluid retention","Pregnancy, co-administration with cyclosporine A or glyburide"
V,Bosutinib,"Kinase inhibitor",Treatment of chronic myeloid leukemia,"Diarrhea, nausea, rash",Monitor liver function and for fluid retention.
W,Brentuximab vedotin,"Antibody-drug conjugate",Treatment of Hodgkin lymphoma and anaplastic large cell lymphoma,"Peripheral neuropathy, neutropenia, fatigue",Monitor for neuropathy and blood counts.
X,Brigatinib,"Kinase inhibitor",Treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer,"Hypertension, visual disturbances, increased CPK",Monitor blood pressure and vision.
Z,Brimonidine,"Alpha-adrenergic agonist",Reduction of intraocular pressure in glaucoma,"Allergic conjunctivitis, eye pruritus, oral dryness",Use caution in patients with cardiovascular disease.
A1,Budesonide,"Corticosteroid",Treatment of asthma and inflammatory bowel disease,"Respiratory infection, headache, oral candidiasis (inhaled)",Rinse mouth after using inhaled form.
B1,Buprenorphine,"Opioid partial agonist",Treatment of opioid dependence and pain,"Respiratory depression, sedation, dependence",Risk of misuse and addiction.
C1,Bupropion,"Antidepressant",Treatment of depression and for smoking cessation,"Insomnia, dry mouth, agitation","Seizure disorder, history of anorexia/bulimia"
D1,Busulfan,"Alkylating agent",Used in preparation for hematopoietic stem cell transplantation,"Myelosuppression, pulmonary fibrosis, nausea",Monitor blood counts and pulmonary function.
E1,Cabazitaxel,"Taxane",Treatment of metastatic castration-resistant prostate cancer,"Neutropenia, diarrhea, fatigue",Premedicate with corticosteroids and antihistamines.
F1,Cabozantinib,"Kinase inhibitor",Treatment of renal cell carcinoma and hepatocellular carcinoma,"Hypertension, diarrhea, fatigue",Risk of hemorrhage and gastrointestinal perforations.
G1,Calcipotriene,"Vitamin D analog",Treatment of psoriasis,"Skin irritation, burning, itching",Do not apply to the face.
H1,Canagliflozin,"SGLT2 inhibitor",Improves glycemic control in type 2 diabetes,"Genital mycotic infections, urinary tract infections, increased urination",Risk of lower limb amputation.
I1,Candesartan,"Angiotensin II receptor blocker (ARB)",Treatment of hypertension and heart failure,"Hypotension, hyperkalemia, dizziness",Avoid in pregnancy.
J1,Capecitabine,"Fluoropyrimidine",Treatment of various cancers, including breast and colorectal cancer,"Hand-foot syndrome, diarrhea, nausea",Monitor for diarrhea and hand-foot syndrome.
K1,Captopril,"ACE inhibitor",Treatment of hypertension and heart failure,"Cough, hypotension, hyperkalemia",Can cause angioedema.
L1,Carbamazepine,"Anticonvulsant",Treatment of epilepsy, trigeminal neuralgia, and bipolar disorder,"Dizziness, drowsiness, ataxia","Serious dermatologic reactions (especially in patients with HLA-B*1502 allele), aplastic anemia"
M1,Carbidopa,"Decarboxylase inhibitor",Used with levodopa for the treatment of Parkinson's disease,"Nausea, dizziness",N/A
N1,Carboplatin,"Platinum-based chemotherapy",Treatment of various cancers, especially ovarian cancer,"Myelosuppression, nausea, nephrotoxicity",Dose is calculated based on renal function.
O1,Carfilzomib,"Proteasome inhibitor",Treatment of multiple myeloma,"Fatigue, nausea, thrombocytopenia",Risk of cardiac toxicity and pulmonary hypertension.
P1,Carvedilol,"Beta-blocker",Treatment of heart failure and hypertension,"Dizziness, fatigue, hypotension",Take with food.
Q1,Cefaclor,"Cephalosporin antibiotic",Treatment of bacterial infections,"Diarrhea, rash, nausea",Allergy to cephalosporins or penicillins.
R1,Cefdinir,"Cephalosporin antibiotic",Treatment of bacterial infections,"Diarrhea, rash",May cause reddish stools.
S1,Cefepime,"Cephalosporin antibiotic",Treatment of moderate to severe bacterial infections,"Rash, diarrhea, positive Coombs' test",Risk of neurotoxicity in patients with renal impairment.
T1,Cefixime,"Cephalosporin antibiotic",Treatment of bacterial infections,"Diarrhea, nausea, abdominal pain",Allergy to cephalosporins or penicillins.
U1,Cefotaxime,"Cephalosporin antibiotic",Treatment of various bacterial infections,"Injection site inflammation, rash, diarrhea",Allergy to cephalosporins or penicillins.
V1,Ceftazidime,"Cephalosporin antibiotic",Treatment of bacterial infections, particularly Pseudomonas aeruginosa,"Injection site reactions, rash, diarrhea",Allergy to cephalosporins or penicillins.
W1,Ceftriaxone,"Cephalosporin antibiotic",Treatment of a wide range of bacterial infections,"Injection site pain, rash, diarrhea","Hyperbilirubinemic neonates, concurrent use with calcium-containing IV solutions"
X1,Celecoxib,"NSAID (COX-2 inhibitor)",Relief of pain and inflammation,"Abdominal pain, dyspepsia, increased risk of cardiovascular events","Aspirin-sensitive asthma, history of cardiovascular disease"
Y1,Cephalexin,"Cephalosporin antibiotic",Treatment of bacterial infections,"Diarrhea, nausea, rash",Allergy to cephalosporins or penicillins.
Z1,Ceritinib,"Kinase inhibitor",Treatment of ALK-positive metastatic non-small cell lung cancer,"Hepatotoxicity, hyperglycemia, diarrhea",Monitor liver function and blood glucose.
A2,Certolizumab pegol,"TNF blocker",Treatment of Crohn's disease, rheumatoid arthritis, and other inflammatory conditions,"Increased risk of infections, injection site reactions",Do not use in patients with active infections.
B2,Cetirizine,"Antihistamine",Relief of allergy symptoms,"Drowsiness, fatigue, dry mouth",Use with caution when driving or operating machinery.
C2,Chlorambucil,"Alkylating agent",Treatment of chronic lymphocytic leukemia and some lymphomas,"Bone marrow suppression, nausea",Monitor blood counts.
D2,Chlordiazepoxide,"Benzodiazepine",Management of anxiety and alcohol withdrawal,"Drowsiness, dizziness, confusion",Risk of dependence.
E2,Chloroquine,"Antimalarial and antirheumatic",Treatment and prevention of malaria; treatment of amebiasis,"Nausea, headache, visual disturbances",Use with caution in patients with psoriasis or porphyria.
F2,Chlorpromazine,"Typical antipsychotic",Treatment of schizophrenia and other psychotic disorders,"Sedation, orthostatic hypotension, tardive dyskinesia",Neuroleptic malignant syndrome.
G2,Chlorthalidone,"Thiazide-like diuretic",Treatment of hypertension and edema,"Hypokalemia, dizziness, hyperglycemia",Monitor electrolytes.
H2,Ciclesonide,"Corticosteroid",Maintenance treatment of asthma,"Headache, nasopharyngitis, oral candidiasis (inhaled)",Not for acute bronchospasm.
I2,Cilostazol,"Phosphodiesterase-3 inhibitor",Reduction of symptoms of intermittent claudication,"Headache, palpitations, diarrhea","Use is contraindicated in patients with heart failure of any severity."
J2,Cimetidine,"H2 receptor antagonist",Treatment of heartburn and ulcers,"Headache, dizziness, diarrhea",Can inhibit metabolism of other drugs.
K2,Ciprofloxacin,"Fluoroquinolone antibiotic",Treatment of bacterial infections,"Nausea, diarrhea, photosensitivity","Risk of tendinitis and tendon rupture, exacerbation of myasthenia gravis"
L2,Cisplatin,"Platinum-based chemotherapy",Treatment of various cancers,"Nephrotoxicity, ototoxicity, severe nausea and vomiting",Ensure adequate hydration.
M2,Citalopram,"SSRI antidepressant",Treatment of depression,"Nausea, drowsiness, insomnia",QT prolongation at doses > 40 mg/day.
N2,Cladribine,"Purine antimetabolite",Treatment of hairy cell leukemia and multiple sclerosis,"Myelosuppression, increased risk of infection, neurotoxicity",Monitor blood counts.
O2,Clarithromycin,"Macrolide antibiotic",Treatment of bacterial infections,"Diarrhea, nausea, abnormal taste",QT prolongation, interacts with many drugs.
P2,Clindamycin,"Lincosamide antibiotic",Treatment of serious bacterial infections,"Diarrhea, pseudomembranous colitis, rash",Risk of C. difficile-associated diarrhea.
Q2,Clobetasol,"Corticosteroid",Treatment of severe skin conditions,"Burning, itching, skin atrophy",Potent corticosteroid; use for short durations.
R2,Clomipramine,"Tricyclic antidepressant",Treatment of obsessive-compulsive disorder (OCD),"Drowsiness, dry mouth, constipation","Increased risk of suicidal thoughts, seizures"
S2,Clonazepam,"Benzodiazepine",Treatment of seizure disorders and panic disorder,"Drowsiness, ataxia, dependence",Avoid abrupt withdrawal.
T2,Clonidine,"Alpha-2 adrenergic agonist",Treatment of hypertension and ADHD,"Drowsiness, dry mouth, dizziness",Do not discontinue abruptly.
U2,Clopidogrel,"Antiplatelet agent",Prevention of blood clots,"Bleeding",Effectiveness can be reduced in poor metabolizers of CYP2C19.
V2,Clozapine,"Atypical antipsychotic",Treatment-resistant schizophrenia,"Agranulocytosis, seizures, myocarditis",Requires strict blood monitoring.
W2,Cobimetinib,"MEK inhibitor",Treatment of melanoma with a BRAF V600E or V600K mutation (in combination with vemurafenib),"Diarrhea, rash, nausea",Risk of cardiomyopathy and ocular toxicities.
X2,Codeine,"Opioid analgesic and antitussive",Relief of mild to moderate pain and cough,"Drowsiness, constipation, respiratory depression","Respiratory depression, ultrarapid metabolizers of CYP2D6"
Y2,Colchicine,"Antigout agent",Treatment and prevention of gout flares,"Diarrhea, nausea, vomiting",Narrow therapeutic index; toxicity can be severe.
Z2,Crizotinib,"Kinase inhibitor",Treatment of ALK-positive or ROS1-positive metastatic non-small cell lung cancer,"Vision disorders, hepatotoxicity, nausea",Monitor liver function and for visual changes.
A3,Cyclobenzaprine,"Muscle relaxant",Relief of muscle spasms,"Drowsiness, dry mouth, dizziness",Structurally related to tricyclic antidepressants.
B3,Cyclophosphamide,"Alkylating agent",Treatment of various cancers and autoimmune disorders,"Myelosuppression, hemorrhagic cystitis, nausea",Maintain adequate hydration.
C3,Cyclosporine,"Calcineurin inhibitor",Prevention of organ transplant rejection and treatment of autoimmune diseases,"Nephrotoxicity, hypertension, increased risk of infections",Requires therapeutic drug monitoring.
D3,Cyproheptadine,"Antihistamine and antiserotonergic agent",Relief of allergy symptoms and appetite stimulant,"Drowsiness, increased appetite, dry mouth",Use with caution in elderly.
E3,Dabigatran,"Direct thrombin inhibitor",Prevention and treatment of blood clots,"Bleeding, dyspepsia",No specific antidote for major bleeding initially.
F3,Dabrafenib,"Kinase inhibitor",Treatment of BRAF V600-mutated melanoma and non-small cell lung cancer,"Hyperkeratosis, headache, fever",Risk of new skin cancers.
G3,Dacarbazine,"Alkylating agent",Treatment of metastatic melanoma and Hodgkin lymphoma,"Severe nausea and vomiting, myelosuppression",Extravasation can cause severe tissue damage.
H3,Dapagliflozin,"SGLT2 inhibitor",Improves glycemic control in type 2 diabetes,"Genital mycotic infections, urinary tract infections",Risk of ketoacidosis.
I3,Daptomycin,"Lipopeptide antibiotic",Treatment of complicated skin and bloodstream infections,"Myopathy, eosinophilic pneumonia",Monitor CPK levels.
J3,Darunavir,"Protease inhibitor",Treatment of HIV infection (used with a booster like ritonavir or cobicistat),"Diarrhea, nausea, rash",Use with caution in patients with sulfa allergy.
K3,Dasatinib,"Kinase inhibitor",Treatment of chronic myeloid leukemia and acute lymphoblastic leukemia,"Myelosuppression, fluid retention, diarrhea",Risk of pulmonary arterial hypertension.
L3,Deferasirox,"Iron chelator",Treatment of chronic iron overload,"Nausea, abdominal pain, renal and hepatic toxicity",Monitor renal and liver function.
M3,Degarelix,"GnRH antagonist",Treatment of advanced prostate cancer,"Injection site reactions, hot flashes",N/A
N3,Denosumab,"RANK ligand inhibitor",Treatment of osteoporosis and prevention of skeletal-related events in cancer,"Musculoskeletal pain, increased risk of infections, osteonecrosis of the jaw",Hypocalcemia must be corrected before starting.
O3,Desipramine,"Tricyclic antidepressant",Treatment of depression,"Drowsiness, dry mouth, constipation",Increased risk of suicidal thoughts.
P3,Desloratadine,"Antihistamine",Relief of allergy symptoms,"Headache, fatigue, dry mouth",Non-sedating.
Q3,Desmopressin,"Synthetic analog of vasopressin",Treatment of diabetes insipidus and nocturnal enuresis,"Hyponatremia, headache, nausea",Risk of water intoxication and hyponatremia.
R3,Dexamethasone,"Corticosteroid",Treatment of inflammatory and autoimmune conditions,"Insomnia, mood changes, hyperglycemia",Many uses and side effects.
S3,Dexlansoprazole,"Proton pump inhibitor (PPI)",Treatment of GERD and erosive esophagitis,"Diarrhea, abdominal pain, nausea",Long-term use may increase risk of fractures and C. difficile infection.
T3,Dexmethylphenidate,"Stimulant",Treatment of ADHD,"Insomnia, decreased appetite, headache",Potential for abuse and dependence.
U3,Dextroamphetamine,"Stimulant",Treatment of ADHD and narcolepsy,"Insomnia, tachycardia, decreased appetite",High potential for abuse.
V3,Diazepam,"Benzodiazepine",Management of anxiety, seizures, and muscle spasms,"Drowsiness, ataxia, dependence",Avoid abrupt discontinuation.
W3,Diclofenac,"NSAID",Relief of pain and inflammation,"GI bleeding, increased risk of cardiovascular events",Topical and oral formulations available.
X3,Dicyclomine,"Anticholinergic",Treatment of irritable bowel syndrome (IBS),"Drowsiness, dry mouth, blurred vision",Use with caution in the elderly.
Y3,Digoxin,"Cardiac glycoside",Treatment of heart failure and atrial fibrillation,"Nausea, vomiting, visual disturbances",Narrow therapeutic index; monitor levels.
Z3,Dihydroergotamine,"Ergot alkaloid",Treatment of migraine headaches,"Nausea, dizziness, vasospasm",Contraindicated in patients with coronary artery disease or uncontrolled hypertension.
A4,Diltiazem,"Calcium channel blocker",Treatment of hypertension, angina, and certain arrhythmias,"Edema, headache, dizziness",Use with caution in patients with heart failure.
B4,Diphenhydramine,"Antihistamine",Relief of allergy symptoms, insomnia, and motion sickness,"Drowsiness, dry mouth, confusion",Significant sedative and anticholinergic effects.
C4,Disopyramide,"Antiarrhythmic",Treatment of ventricular arrhythmias,"Anticholinergic effects (dry mouth, urinary retention), hypotension",Can worsen heart failure.
D4,Divalproex,"Anticonvulsant",Treatment of seizures, bipolar disorder, and migraine prevention,"Hepatotoxicity, pancreatitis, thrombocytopenia","Pregnancy (neural tube defects), liver disease"
E4,Docetaxel,"Taxane",Treatment of various cancers, including breast, prostate, and lung cancer,"Neutropenia, fluid retention, neuropathy",Premedicate with corticosteroids.
F4,Dofetilide,"Antiarrhythmic",Maintenance of normal sinus rhythm in patients with atrial fibrillation,"QT prolongation, torsades de pointes",Requires inpatient initiation with ECG monitoring.
G4,Dolasetron,"5-HT3 receptor antagonist",Prevention of nausea and vomiting associated with chemotherapy,"Headache, ECG changes (QT prolongation)",IV formulation is no longer indicated for CINV due to cardiac risk.
H4,Dolutegravir,"Integrase inhibitor",Treatment of HIV-1 infection,"Insomnia, headache, dizziness",Can increase creatinine without affecting renal function.
I4,Donepezil,"Cholinesterase inhibitor",Treatment of Alzheimer's disease,"Nausea, diarrhea, insomnia",May cause bradycardia.
J4,Dopamine,"Adrenergic agonist",Treatment of shock and hypotension,"Tachycardia, arrhythmias, hypertension",Administered by IV infusion.
K4,Dornase alfa,"Mucolytic enzyme",Management of cystic fibrosis,"Pharyngitis, voice alteration, rash",Administered via nebulizer.
L4,Doxazosin,"Alpha-1 blocker",Treatment of hypertension and benign prostatic hyperplasia (BPH),"Dizziness, fatigue, orthostatic hypotension",Risk of first-dose syncope.
M4,Doxepin,"Tricyclic antidepressant/Antihistamine",Treatment of depression, anxiety, and insomnia,"Drowsiness, dry mouth, blurred vision",Varies by indication and formulation.
N4,Doxorubicin,"Anthracycline chemotherapy",Treatment of various cancers,"Cardiotoxicity, myelosuppression, nausea",Lifetime cumulative dose limitations.
O4,Doxycycline,"Tetracycline antibiotic",Treatment of bacterial and other infections,"Photosensitivity, nausea, GI upset",Do not take with dairy or antacids; avoid in children <8 and pregnancy.
P4,Dronabinol,"Cannabinoid",Treatment of nausea and vomiting from chemotherapy; appetite stimulant in AIDS,"Drowsiness, dizziness, euphoria",Potential for psychoactive effects.
Q4,Drospirenone,"Progestin",Used in oral contraceptives,"Increased risk of venous thromboembolism, hyperkalemia",Monitor potassium if used with other drugs that increase potassium.
R4,Dulaglutide,"GLP-1 receptor agonist",Improves glycemic control in type 2 diabetes,"Nausea, diarrhea, risk of thyroid C-cell tumors",Administered once weekly by subcutaneous injection.
S4,Duloxetine,"SNRI antidepressant",Treatment of depression, anxiety, and neuropathic pain,"Nausea, dry mouth, insomnia",Can increase blood pressure.
T4,Dutasteride,"5-alpha-reductase inhibitor",Treatment of benign prostatic hyperplasia (BPH),"Impotence, decreased libido, gynecomastia",Pregnant women should not handle capsules.
U4,Eculizumab,"Complement inhibitor",Treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome,"Increased risk of meningococcal infections, headache, nasopharyngitis",Vaccinate against Neisseria meningitidis before starting.
V4,Edoxaban,"Factor Xa inhibitor",Prevention and treatment of blood clots,"Bleeding",Do not use in patients with CrCl > 95 mL/min for nonvalvular atrial fibrillation.
W4,Efavirenz,"NNRTI",Treatment of HIV-1 infection,"Dizziness, rash, abnormal dreams",Can cause psychiatric symptoms and CNS effects.
X4,Efinaconazole,"Antifungal",Topical treatment of onychomycosis of the toenails,"Ingrown toenail, application site dermatitis, pain",Topical solution applied once daily.
Y4,Elbasvir/grazoprevir,"Direct-acting antiviral combination",Treatment of chronic hepatitis C virus (HCV) infection,"Fatigue, headache, nausea",Test for HBV infection before starting.
Z4,Eletriptan,"5-HT1 receptor agonist (triptan)",Acute treatment of migraine,"Dizziness, nausea, chest tightness",Contraindicated in ischemic heart disease.
A5,Eliglustat,"Glucosylceramide synthase inhibitor",Treatment of Gaucher disease type 1,"Arthralgia, headache, diarrhea",CYP2D6 and CYP3A4 substrate; requires genotyping for CYP2D6 status.
B5,Elotuzumab,"SLAMF7-directed immunostimulatory antibody",Treatment of multiple myeloma (in combination with other drugs),"Infusion reactions, increased risk of infections, fatigue",Premedicate to reduce infusion reactions.
C5,Eltrombopag,"Thrombopoietin receptor agonist",Treatment of thrombocytopenia,"Hepatotoxicity, thrombotic events, nausea",Monitor liver function.
D5,Elvitegravir,"Integrase inhibitor",Treatment of HIV-1 infection (available only in combination products),"Nausea, diarrhea, headache",Must be co-administered with a pharmacokinetic enhancer (cobicistat).
E5,Empagliflozin,"SGLT2 inhibitor",Improves glycemic control in type 2 diabetes; reduces risk of cardiovascular death,"Genital mycotic infections, urinary tract infections",Risk of ketoacidosis and Fournier's gangrene.
F5,Enalapril,"ACE inhibitor",Treatment of hypertension and heart failure,"Cough, hypotension, dizziness",Can cause angioedema and hyperkalemia.
G5,Encorafenib,"Kinase inhibitor",Treatment of BRAF-mutated melanoma (in combination with binimetinib),"Fatigue, nausea, rash",Risk of new skin cancers and QT prolongation.
H5,Enzalutamide,"Androgen receptor inhibitor",Treatment of metastatic castration-resistant prostate cancer,"Fatigue, hot flashes, hypertension",Risk of seizures.
I5,Enzymatic debriding agents,N/A,Topical treatment for the debridement of chronic dermal ulcers and burns,"Pain, bleeding, dermatitis",N/A
J5,Epinephrine,"Adrenergic agonist",Treatment of anaphylaxis, asthma, and cardiac arrest,"Tachycardia, hypertension, anxiety",Available in various formulations for different uses (e.g., auto-injector for anaphylaxis).
K5,Epirubicin,"Anthracycline chemotherapy",Treatment of breast cancer,"Cardiotoxicity, myelosuppression, nausea",Similar to doxorubicin.
L5,Eplerenone,"Aldosterone antagonist",Treatment of hypertension and heart failure post-myocardial infarction,"Hyperkalemia, dizziness",More selective than spironolactone with fewer hormonal side effects.
M5,Epoetin alfa,"Erythropoiesis-stimulating agent (ESA)",Treatment of anemia due to chronic kidney disease or chemotherapy,"Hypertension, increased risk of thrombosis",Target hemoglobin should not exceed 11 g/dL.
N5,Eribulin,"Microtubule inhibitor",Treatment of metastatic breast cancer and liposarcoma,"Neutropenia, peripheral neuropathy, fatigue",Monitor blood counts and for neuropathy.
O5,Erlotinib,"Kinase inhibitor (EGFR inhibitor)",Treatment of non-small cell lung cancer and pancreatic cancer,"Rash, diarrhea, fatigue",Effectiveness is higher in patients with EGFR mutations.
P5,Erythromycin,"Macrolide antibiotic",Treatment of various bacterial infections,"GI upset (nausea, cramping), QT prolongation",Potent inhibitor of CYP3A4, leading to many drug interactions.
Q5,Escitalopram,"SSRI antidepressant",Treatment of depression and generalized anxiety disorder,"Nausea, insomnia, drowsiness",Considered the S-enantiomer of citalopram.
R5,Eslicarbazepine,"Anticonvulsant",Adjunctive treatment of partial-onset seizures,"Dizziness, somnolence, diplopia",Prodrug of licarbazepine.
S5,Esomeprazole,"Proton pump inhibitor (PPI)",Treatment of GERD, ulcers, and Zollinger-Ellison syndrome,"Headache, diarrhea, abdominal pain",Similar to omeprazole.
T5,Estazolam,"Benzodiazepine",Short-term management of insomnia,"Drowsiness, dizziness, ataxia",Potential for dependence.
U5,Estradiol,"Estrogen",Hormone replacement therapy, treatment of symptoms of menopause,"Nausea, headache, breast tenderness",Increased risk of cardiovascular events and certain cancers.
V5,Eszopiclone,"Nonbenzodiazepine hypnotic",Treatment of insomnia,"Unpleasant taste, drowsiness, dizziness",Potential for complex sleep-related behaviors.
W5,Etanercept,"TNF blocker",Treatment of rheumatoid arthritis, psoriasis, and other inflammatory diseases,"Injection site reactions, increased risk of infections",Do not use in patients with active infections or sepsis.
X5,Ethambutol,"Antimycobacterial",Treatment of tuberculosis (part of a multi-drug regimen),"Optic neuritis (visual changes), rash",Requires baseline and regular vision monitoring.
Y5,Ethinyl estradiol,"Synthetic estrogen",Component of most combination oral contraceptives,"Nausea, breast tenderness, risk of VTE",Dose and progestin component vary widely among products.
Z5,Ethosuximide,"Anticonvulsant",Treatment of absence seizures,"Nausea, drowsiness, hiccups",Can cause blood dyscrasias.
A6,Etodolac,"NSAID",Relief of pain and inflammation,"GI upset, increased risk of cardiovascular events",N/A
B6,Etonogestrel,"Progestin",Used in hormonal contraceptives (e.g., implants, vaginal rings),"Irregular bleeding, headache, weight gain",N/A
C6,Etoposide,"Topoisomerase II inhibitor",Treatment of various cancers, including lung and testicular cancer,"Myelosuppression, alopecia, nausea",Administer slowly to avoid hypotension.
D6,Everolimus,"mTOR inhibitor",Treatment of various cancers and prevention of organ transplant rejection,"Stomatitis, rash, increased risk of infections",Requires therapeutic drug monitoring for transplant use.
E6,Exemestane,"Aromatase inhibitor",Treatment of hormone receptor-positive breast cancer in postmenopausal women,"Hot flashes, fatigue, arthralgia",Irreversible steroidal inhibitor.
F6,Ezetimibe,"Cholesterol absorption inhibitor",Lowers high cholesterol levels (often used with a statin),"Upper respiratory tract infection, diarrhea, arthralgia",N/A
G6,Famotidine,"H2 receptor antagonist",Treatment and prevention of heartburn and ulcers,"Headache, dizziness, constipation",Fewer drug interactions than cimetidine.
H6,Febuxostat,"Xanthine oxidase inhibitor",Treatment of gout,"Liver function abnormalities, nausea, rash",Higher risk of cardiovascular death compared to allopurinol in one study.
I6,Felodipine,"Calcium channel blocker",Treatment of hypertension,"Peripheral edema, headache, flushing",Grapefruit juice can increase levels.
J6,Fenofibrate,"Fibrate",Lowers triglycerides and LDL cholesterol,"Abnormal liver function tests, myopathy (risk increases with statins)",Monitor liver enzymes.
K6,Fentanyl,"Opioid analgesic",Management of severe pain,"Respiratory depression, sedation, constipation",Extremely potent; high potential for abuse and overdose.
L6,Fidaxomicin,"Macrolide antibiotic",Treatment of Clostridioides difficile-associated diarrhea (CDAD),"Nausea, abdominal pain",Minimal systemic absorption.
M6,Filgrastim,"Granulocyte colony-stimulating factor (G-CSF)",Prevention of neutropenia in patients receiving chemotherapy,"Bone pain",N/A
N6,Finasteride,"5-alpha-reductase inhibitor",Treatment of BPH and male pattern baldness,"Impotence, decreased libido",Pregnant women should not handle crushed or broken tablets.
O6,Fingolimod,"Sphingosine 1-phosphate receptor modulator",Treatment of multiple sclerosis,"Bradycardia (first-dose), increased risk of infections, macular edema",Requires first-dose observation.
P6,Flecainide,"Antiarrhythmic",Prevention of various arrhythmias,"Dizziness, visual disturbances, proarrhythmic effects",Contraindicated in structural heart disease.
Q6,Fluconazole,"Antifungal",Treatment of various fungal infections, especially Candida,"Headache, nausea, rash",Can inhibit metabolism of other drugs.
R6,Fludarabine,"Purine analog",Treatment of chronic lymphocytic leukemia (CLL),"Myelosuppression, neurotoxicity, increased risk of infections",N/A
S6,Fludrocortisone,"Mineralocorticoid",Replacement therapy for adrenal insufficiency (Addison's disease),"Hypertension, edema, hypokalemia",Requires monitoring of blood pressure and electrolytes.
T6,Flunisolide,"Corticosteroid",Maintenance treatment of asthma (inhaled) or allergic rhinitis (nasal),"Oral candidiasis, hoarseness (inhaled); nasal irritation (nasal)",N/A
U6,Fluocinolone,"Corticosteroid",Topical treatment of skin conditions,"Burning, itching, skin atrophy",Available in various potencies and formulations.
V6,Fluocinonide,"Corticosteroid",Topical treatment of skin conditions,"Burning, itching, skin atrophy",Potent corticosteroid.
W6,Fluorometholone,"Corticosteroid",Ophthalmic treatment of inflammatory eye conditions,"Increased intraocular pressure, cataracts",Requires monitoring of eye pressure with long-term use.
X6,Fluorouracil (5-FU),"Antimetabolite",Treatment of various cancers (systemic); treatment of actinic keratosis (topical),"Myelosuppression, mucositis, diarrhea (systemic); application site reactions (topical)",N/A
Y6,Fluoxetine,"SSRI antidepressant",Treatment of depression, OCD, panic disorder, and bulimia,"Nausea, insomnia, headache",Long half-life.
Z6,Fluphenazine,"Typical antipsychotic",Management of schizophrenia,"Extrapyramidal symptoms, sedation, tardive dyskinesia",Available as long-acting injection.
A7,Flurazepam,"Benzodiazepine",Treatment of insomnia,"Drowsiness, dizziness, long half-life leads to next-day sedation",N/A
B7,Flurbiprofen,"NSAID",Relief of pain and inflammation,"GI upset, increased risk of cardiovascular events",Available as ophthalmic solution for inhibition of intraoperative miosis.
C7,Flutamide,"Androgen receptor inhibitor",Treatment of prostate cancer,"Hot flashes, gynecomastia, diarrhea",Risk of hepatotoxicity.
D7,Fluticasone,"Corticosteroid",Treatment of asthma (inhaled) and allergic rhinitis (nasal),"Oral candidiasis, hoarseness (inhaled); nasal irritation (nasal)",Available in combination with salmeterol or vilanterol.
E7,Fluvastatin,"HMG-CoA reductase inhibitor (statin)",Lowers high cholesterol levels,"Headache, dyspepsia",Generally less potent than other statins.
F7,Fluvoxamine,"SSRI antidepressant",Treatment of obsessive-compulsive disorder (OCD) and social anxiety disorder,"Nausea, drowsiness, weakness",Potent inhibitor of CYP1A2 and CYP2C19.
G7,Folic acid,"Vitamin",Treatment and prevention of folic acid deficiency, prevention of neural tube defects,"N/A (generally well-tolerated)",N/A
H7,Fondaparinux,"Factor Xa inhibitor",Prevention and treatment of venous thromboembolism,"Bleeding",Administered subcutaneously.
I7,Formoterol,"Long-acting beta-2 agonist (LABA)",Treatment of asthma and COPD (always with an inhaled corticosteroid in asthma),"Tremor, tachycardia, palpitations",Increased risk of asthma-related death when used as monotherapy in asthma.
J7,Fosamprenavir,"Protease inhibitor",Treatment of HIV infection (used with ritonavir),"Rash, nausea, diarrhea",Prodrug of amprenavir.
K7,Fosaprepitant,"Neurokinin-1 receptor antagonist",Prevention of chemotherapy-induced nausea and vomiting,"Infusion site reactions, fatigue, hiccups",IV prodrug of aprepitant.
L7,Foscarnet,"Antiviral",Treatment of CMV retinitis and acyclovir-resistant herpes infections,"Nephrotoxicity, electrolyte abnormalities",Requires close monitoring of renal function and electrolytes.
M7,Fosinopril,"ACE inhibitor",Treatment of hypertension and heart failure,"Cough, dizziness",Dual routes of elimination (hepatic and renal).
N7,Furosemide,"Loop diuretic",Treatment of edema and hypertension,"Hypokalemia, dehydration, ototoxicity",Potent diuretic.
O7,Gabapentin,"Anticonvulsant/Neuropathic pain agent",Treatment of seizures and neuropathic pain,"Drowsiness, dizziness, ataxia",Also used for restless legs syndrome.
P7,Galantamine,"Cholinesterase inhibitor",Treatment of Alzheimer's disease,"Nausea, vomiting, diarrhea",N/A
Q7,Ganciclovir,"Antiviral",Treatment and prevention of cytomegalovirus (CMV) infection,"Myelosuppression (neutropenia, thrombocytopenia)","Carcinogenic, teratogenic, and causes aspermatogenesis in animals"
R7,Gemcitabine,"Antimetabolite",Treatment of various cancers, including pancreatic, lung, and breast,"Myelosuppression, nausea, flu-like symptoms",N/A
S7,Gemfibrozil,"Fibrate",Lowers triglycerides,"Dyspepsia, myopathy (risk increases with statins)",Inhibits metabolism of statins, increasing risk of myopathy.
T7,Gentamicin,"Aminoglycoside antibiotic",Treatment of serious bacterial infections,"Nephrotoxicity, ototoxicity",Monitor renal function and drug levels.
U7,Glatiramer,"Immunomodulator",Treatment of multiple sclerosis,"Injection site reactions, flushing, chest pain",N/A
V7,Glecaprevir/pibrentasvir,"Direct-acting antiviral combination",Treatment of chronic hepatitis C virus (HCV) infection,"Headache, fatigue",Effective against all major HCV genotypes.
W7,Glimepiride,"Sulfonylurea",Improves glycemic control in type 2 diabetes,"Hypoglycemia, dizziness, weight gain",Risk of hypoglycemia is a major concern.
X7,Glipizide,"Sulfonylurea",Improves glycemic control in type 2 diabetes,"Hypoglycemia, nausea, weight gain",Take 30 minutes before a meal.
Y7,Glyburide,"Sulfonylurea",Improves glycemic control in type 2 diabetes,"Hypoglycemia, weight gain",Higher risk of hypoglycemia than other sulfonylureas.
Z7,Golimumab,"TNF blocker",Treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis,"Increased risk of infections, injection site reactions",Administered subcutaneously or intravenously.
A8,Goserelin,"GnRH agonist",Treatment of prostate cancer and breast cancer,"Hot flashes, decreased libido",Administered as a subcutaneous implant.
B8,Granisetron,"5-HT3 receptor antagonist",Prevention of nausea and vomiting,"Headache, constipation",Available as oral, IV, and transdermal patch.
C8,Griseofulvin,"Antifungal",Treatment of fungal infections of the skin, hair, and nails,"Headache, nausea, photosensitivity",Take with a fatty meal to increase absorption.
D8,Guaifenesin,"Expectorant",Helps loosen phlegm and thin bronchial secretions,"Dizziness, headache, nausea",Often found in combination cold and cough products.
E8,Guanfacine,"Alpha-2A adrenergic agonist",Treatment of ADHD and hypertension,"Drowsiness, dizziness, dry mouth",Do not discontinue abruptly.
F8,Haloperidol,"Typical antipsychotic",Treatment of schizophrenia and Tourette's syndrome,"Extrapyramidal symptoms, QT prolongation, tardive dyskinesia",High potency antipsychotic.
G8,Hydralazine,"Vasodilator",Treatment of hypertension,"Headache, tachycardia, lupus-like syndrome",Can cause reflex tachycardia.
H8,Hydrochlorothiazide (HCTZ),"Thiazide diuretic",Treatment of hypertension and edema,"Hypokalemia, dizziness, photosensitivity",Commonly used in combination with other antihypertensives.
I8,Hydrocodone,"Opioid analgesic",Relief of moderate to severe pain,"Drowsiness, constipation, respiratory depression",Almost always found in combination with acetaminophen or ibuprofen.
J8,Hydrocortisone,"Corticosteroid",Treatment of inflammation and adrenal insufficiency,"Many side effects with systemic use; skin atrophy with topical use",Available in many formulations (oral, topical, IV).
K8,Hydromorphone,"Opioid analgesic",Management of severe pain,"Respiratory depression, sedation, constipation",More potent than morphine.
L8,Hydroxychloroquine,"Antimalarial and antirheumatic",Treatment of malaria, lupus, and rheumatoid arthritis,"Retinopathy (requires eye exams), nausea, headache",N/A
M8,Hydroxyurea,"Antineoplastic/Antisickling agent",Treatment of certain cancers and sickle cell disease,"Myelosuppression, nausea",Increases fetal hemoglobin in sickle cell disease.
N8,Hydroxyzine,"Antihistamine",Treatment of anxiety, pruritus, and as a sedative,"Drowsiness, dry mouth",Potent antihistamine with sedative properties.
O8,Ibandronate,"Bisphosphonate",Treatment and prevention of postmenopausal osteoporosis,"Dyspepsia, back pain, flu-like symptoms",Can be taken once monthly (oral) or every 3 months (IV).
P8,Ibrutinib,"Kinase inhibitor (BTK inhibitor)",Treatment of various B-cell cancers like CLL and mantle cell lymphoma,"Bleeding, atrial fibrillation, diarrhea",Monitor for bleeding and cardiac arrhythmias.
Q8,Ibuprofen,"NSAID",Relief of pain, fever, and inflammation,"GI upset, increased risk of cardiovascular events and GI bleeding",Available over-the-counter and by prescription.
R8,Icatibant,"Bradykinin B2 receptor antagonist",Treatment of acute attacks of hereditary angioedema (HAE),"Injection site reactions",Administered by subcutaneous injection.
S8,Idarucizumab,"Monoclonal antibody fragment",Specific reversal agent for dabigatran,"No common side effects reported; risk of thrombosis",N/A
T8,Idelalisib,"PI3K inhibitor",Treatment of certain B-cell cancers,"Severe diarrhea/colitis, hepatotoxicity, pneumonitis",Boxed warnings for toxicities.
U8,Ifosfamide,"Alkylating agent",Treatment of various cancers, particularly testicular cancer,"Hemorrhagic cystitis, neurotoxicity, myelosuppression",Co-administer with mesna to prevent bladder toxicity.
V8,Imatinib,"Kinase inhibitor (BCR-ABL inhibitor)",Treatment of chronic myeloid leukemia (CML) and GIST,"Fluid retention, muscle cramps, nausea",Take with food and a large glass of water.
W8,Imipramine,"Tricyclic antidepressant",Treatment of depression,"Drowsiness, dry mouth, constipation",N/A
X8,Imiquimod,"Immune response modifier",Topical treatment of genital warts, actinic keratosis, and superficial basal cell carcinoma,"Application site reactions (redness, itching, swelling)",N/A
Y8,Indacaterol,"Long-acting beta-2 agonist (LABA)",Long-term maintenance treatment of COPD,"Nasopharyngitis, cough, headache",Inhaled once daily.
Z8,Indomethacin,"NSAID",Relief of pain and inflammation,"Headache, dizziness, GI upset",One of the more potent NSAIDs.
A9,Infliximab,"TNF blocker",Treatment of various inflammatory diseases like rheumatoid arthritis and Crohn's disease,"Infusion reactions, increased risk of infections",Administered by intravenous infusion.
B9,Ingenol mebutate,"Inducer of cell death",Topical treatment of actinic keratosis,"Application site reactions (erythema, flaking, crusting)","Severe eye injury and allergic reactions have occurred. Do not apply near eyes or mouth."
C9,Insulin,"Hormone",Treatment of diabetes mellitus,"Hypoglycemia, weight gain",Many types exist with different onsets and durations of action (e.g., Lispro, Glargine, NPH).
D9,Interferon alfa,"Cytokine",Treatment of hepatitis, some cancers, and genital warts,"Flu-like symptoms, depression, myelosuppression",Many subtypes and formulations.
E9,Ipilimumab,"CTLA-4-blocking antibody",Treatment of melanoma,"Immune-mediated adverse reactions (colitis, hepatitis, dermatitis)",Can cause severe and fatal immune-mediated reactions.
F9,Irbesartan,"Angiotensin II receptor blocker (ARB)",Treatment of hypertension and diabetic nephropathy,"Dizziness, hyperkalemia",Avoid in pregnancy.
G9,Irinotecan,"Topoisomerase I inhibitor",Treatment of colorectal cancer,"Severe diarrhea, neutropenia",Genetic testing for UGT1A1 can predict risk of toxicity.
H9,Iron Dextran,Iron replacement,Parenteral treatment of iron-deficiency anemia,"Anaphylaxis (boxed warning), hypotension, injection site reactions",Requires a test dose before the first full therapeutic dose.
I9,Isavuconazonium,"Azole antifungal",Treatment of invasive aspergillosis and mucormycosis,"Nausea, vomiting, hepatotoxicity",Prodrug of isavuconazole.
J9,Isocarboxazid,"MAO inhibitor (non-selective)",Treatment of depression,"Orthostatic hypotension, dizziness, hypertensive crisis with tyramine-rich foods",Many food and drug interactions.
K9,Isoniazid,"Antimycobacterial",Treatment and prevention of tuberculosis,"Hepatotoxicity, peripheral neuropathy",Administer with pyridoxine (B6) to reduce neuropathy risk.
L9,Isoproterenol,"Non-selective beta-adrenergic agonist",Treatment of bradycardia and heart block,"Tachycardia, palpitations, arrhythmias",N/A
M9,Isotretinoin,"Retinoid",Treatment of severe nodular acne,"Severe birth defects (boxed warning), dry skin, chapped lips, depression","Pregnancy, requires enrollment in a special restricted distribution program (iPLEDGE)"
N9,Isradipine,"Calcium channel blocker",Treatment of hypertension,"Headache, edema, flushing",N/A
O9,Itraconazole,"Azole antifungal",Treatment of various fungal infections,"Nausea, hepatotoxicity, can worsen heart failure",Potent inhibitor of CYP3A4, many drug interactions.
P9,Ivabradine,"If channel inhibitor",Reduces the risk of hospitalization for worsening heart failure,"Bradycardia, visual brightness (phosphenes), hypertension",N/A
Q9,Ivacaftor,"CFTR potentiator",Treatment of cystic fibrosis in patients with specific CFTR mutations,"Headache, upper respiratory infection, abdominal pain",Take with fat-containing food.
R9,Ivermectin,"Antiparasitic",Treatment of various parasitic infections, such as onchocerciasis and strongyloidiasis,"Dizziness, nausea, pruritus",N/A
S9,Ixazomib,"Proteasome inhibitor",Treatment of multiple myeloma (in combination with lenalidomide and dexamethasone),"Thrombocytopenia, peripheral neuropathy, diarrhea",Oral proteasome inhibitor.
T9,Ketamine,"NMDA receptor antagonist",Anesthetic and analgesic; treatment-resistant depression,"Dissociative reactions, hypertension, increased heart rate",Potential for abuse.
U9,Ketoconazole,"Azole antifungal",Topical treatment of fungal infections; systemic use is limited due to toxicity,"Hepatotoxicity (boxed warning), nausea",Potent CYP3A4 inhibitor. Systemic use only when other effective antifungal therapy is not available or tolerated.
V9,Ketorolac,"NSAID",Short-term management of moderately severe acute pain,"GI bleeding, renal toxicity",Use is limited to 5 days total for all routes combined.
W9,Labetalol,"Beta-blocker with alpha-blocking activity",Treatment of hypertension,"Dizziness, fatigue, nausea",Can be used IV for hypertensive emergencies.
X9,Lacosamide,"Anticonvulsant",Adjunctive treatment of partial-onset seizures,"Dizziness, headache, diplopia",May prolong the PR interval.
Y9,Lamivudine (3TC),"Nucleoside reverse transcriptase inhibitor (NRTI)",Treatment of HIV and chronic hepatitis B,"Headache, nausea, fatigue",Activity against both HIV and HBV.
Z9,Lamotrigine,"Anticonvulsant",Treatment of epilepsy and bipolar disorder,"Serious rash (Stevens-Johnson syndrome) (boxed warning), dizziness, headache",Requires slow dose titration to reduce rash risk.
AA,Lansoprazole,"Proton pump inhibitor (PPI)",Treatment of GERD and ulcers,"Diarrhea, headache",N/A
BB,Lapatinib,"Kinase inhibitor (EGFR and HER2 inhibitor)",Treatment of HER2-positive breast cancer,"Diarrhea, rash, hepatotoxicity",Take at least one hour before or one hour after a meal.
CC,Ledipasvir/sofosbuvir,"Direct-acting antiviral combination",Treatment of chronic hepatitis C,"Fatigue, headache",Single tablet regimen.
DD,Lenalidomide,"Immunomodulatory agent",Treatment of multiple myeloma and myelodysplastic syndromes,"Thromboembolism, myelosuppression, severe birth defects (boxed warning)",Requires enrollment in a restricted distribution program (REMS).
EE,Lenvatinib,"Kinase inhibitor",Treatment of thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma,"Hypertension, fatigue, diarrhea",N/A
FF,Letrozole,"Aromatase inhibitor",Treatment of hormone receptor-positive breast cancer in postmenopausal women,"Hot flashes, arthralgia, fatigue",N/A
GG,Leucovorin,Folinic acid,Rescue therapy after high-dose methotrexate; potentiates fluorouracil,"Allergic reactions",N/A
HH,Leuprolide,"GnRH agonist",Treatment of prostate cancer, endometriosis, and uterine fibroids,"Hot flashes, decreased libido",Administered as a depot injection.
II,Levetiracetam,"Anticonvulsant",Treatment of various seizure types,"Somnolence, dizziness, behavioral changes",Generally well-tolerated with few drug interactions.
JJ,Levobupivacaine,"Local anesthetic",Surgical anesthesia and pain management,"Hypotension, nausea, numbness",Less cardiotoxic than bupivacaine.
KK,Levocetirizine,"Antihistamine",Relief of allergy symptoms,"Somnolence, fatigue",The R-enantiomer of cetirizine.
LL,Levofloxacin,"Fluoroquinolone antibiotic",Treatment of various bacterial infections,"Nausea, photosensitivity, tendinitis risk (boxed warning)",Risk of aortic dissection or rupture.
MM,Levomilnacipran,"SNRI antidepressant",Treatment of major depressive disorder,"Nausea, headache, constipation",Active enantiomer of milnacipran.
NN,Levonorgestrel,"Progestin",Used in hormonal contraceptives and as emergency contraception,"Irregular bleeding, nausea, headache",N/A
OO,Levothyroxine (T4),"Thyroid hormone",Treatment of hypothyroidism,"Hyperthyroidism symptoms if dose is too high (e.g., tachycardia, weight loss)",Take on an empty stomach.
PP,Lidocaine,"Local anesthetic and antiarrhythmic",Local anesthesia and treatment of ventricular arrhythmias,"Drowsiness, dizziness, paresthesias (with systemic use)",N/A
QQ,Linaclotide,"Guanylate cyclase-C agonist",Treatment of IBS with constipation (IBS-C) and chronic idiopathic constipation (CIC),"Diarrhea",Contraindicated in pediatric patients < 6 years old.
RR,Linagliptin,"DPP-4 inhibitor",Improves glycemic control in type 2 diabetes,"Nasopharyngitis",Primarily excreted unchanged in feces.
SS,Linezolid,"Oxazolidinone antibiotic",Treatment of serious gram-positive infections, including MRSA and VRE,"Myelosuppression, peripheral and optic neuropathy, serotonin syndrome",Weak MAO inhibitor; has food and drug interactions.
TT,Liothyronine (T3),"Thyroid hormone",Treatment of hypothyroidism,"Hyperthyroidism symptoms if dose is too high",More potent and shorter half-life than levothyroxine.
UU,Liraglutide,"GLP-1 receptor agonist",Treatment of type 2 diabetes and chronic weight management,"Nausea, risk of thyroid C-cell tumors (boxed warning)",Administered once daily by subcutaneous injection.
VV,Lisdexamfetamine,"Stimulant prodrug",Treatment of ADHD and binge eating disorder,"Decreased appetite, insomnia, dry mouth",Prodrug of dextroamphetamine.
WW,Lisinopril,"ACE inhibitor",Treatment of hypertension and heart failure,"Cough, dizziness, hyperkalemia",N/A
XX,Lithium,"Mood stabilizer",Treatment of bipolar disorder,"Tremor, polyuria, hypothyroidism",Narrow therapeutic index; requires blood level monitoring.
YY,Loperamide,"Opioid-receptor agonist (peripheral)",Treatment of diarrhea,"Constipation, dizziness",Does not cross the blood-brain barrier at normal doses.
ZZ,Lopinavir/ritonavir,"Protease inhibitor combination",Treatment of HIV infection,"Diarrhea, nausea, hyperlipidemia",Ritonavir is used as a pharmacokinetic booster.
A11,Lorazepam,"Benzodiazepine",Management of anxiety, insomnia, and seizures,"Drowsiness, sedation, dependence",N/A
B11,Losartan,"Angiotensin II receptor blocker (ARB)",Treatment of hypertension and diabetic nephropathy,"Dizziness, hyperkalemia",Avoid in pregnancy.
C11,Loteprednol,"Corticosteroid",Ophthalmic treatment of inflammatory eye conditions,"Increased intraocular pressure",N/A
D11,Lovastatin,"HMG-CoA reductase inhibitor (statin)",Lowers high cholesterol levels,"Myopathy, elevated liver enzymes",Take with the evening meal.
E11,Loxapine,"Typical antipsychotic",Treatment of schizophrenia,"Sedation, extrapyramidal symptoms",Inhaled formulation available for acute agitation.
F11,Lubiprostone,"Chloride channel activator",Treatment of chronic constipation and IBS-C,"Nausea, diarrhea, headache",Take with food and water.
G11,Luliconazole,"Azole antifungal",Topical treatment of athlete's foot, jock itch, and ringworm,"Application site reactions",N/A
H11,Lurasidone,"Atypical antipsychotic",Treatment of schizophrenia and bipolar depression,"Somnolence, akathisia, nausea",Take with food (at least 350 calories).
I11,Macitentan,"Endothelin receptor antagonist",Treatment of pulmonary arterial hypertension,"Anemia, nasopharyngitis, headache","Pregnancy (boxed warning)"
J11,Maraviroc,"CCR5 antagonist",Treatment of CCR5-tropic HIV-1 infection,"Cough, fever, hepatotoxicity (boxed warning)",Requires a tropism test before initiation.
K11,Meclizine,"Antihistamine",Treatment of motion sickness and vertigo,"Drowsiness, dry mouth",N/A
L11,Medroxyprogesterone,"Progestin",Hormone therapy, contraception,"Irregular bleeding, weight gain, bone mineral density loss (with long-term depot use)",N/A
M11,Mefloquine,"Antimalarial",Prevention and treatment of malaria,"Neuropsychiatric effects (vivid dreams, anxiety, paranoia) (boxed warning), dizziness",N/A
N11,Megestrol,"Progestin/Appetite stimulant",Palliative treatment of breast/endometrial cancer; treatment of anorexia/cachexia in AIDS,"Weight gain, thromboembolic events",N/A
O11,Meloxicam,"NSAID",Relief of pain and inflammation, particularly for arthritis,"GI upset, increased risk of cardiovascular events",Preferentially inhibits COX-2 over COX-1, but not as selective as celecoxib.
P11,Melphalan,"Alkylating agent",Treatment of multiple myeloma and ovarian cancer,"Myelosuppression, mucositis",N/A
Q11,Memantine,"NMDA receptor antagonist",Treatment of moderate to severe Alzheimer's disease,"Dizziness, headache, confusion",N/A
R11,Mepivacaine,"Local anesthetic",Infiltration and nerve block anesthesia,"N/A",N/A
S11,Mercaptopurine (6-MP),"Purine antimetabolite",Treatment of acute lymphoblastic leukemia (ALL),"Myelosuppression, hepatotoxicity",Genetic testing for TPMT can predict risk of toxicity.
T11,Meropenem,"Carbapenem antibiotic",Treatment of serious multidrug-resistant bacterial infections,"Diarrhea, rash, nausea",Broad-spectrum antibiotic.
U11,Mesalamine (5-ASA),"Aminosalicylate",Treatment of ulcerative colitis,"Headache, abdominal pain, rash",Available in many oral and rectal formulations.
V11,Metformin,"Biguanide",First-line treatment for type 2 diabetes,"GI side effects (diarrhea, nausea), lactic acidosis (rare)",Does not cause hypoglycemia.
W11,Methadone,"Opioid agonist",Treatment of opioid dependence and severe pain,"QT prolongation, respiratory depression, sedation",Long and variable half-life.
X11,Methamphetamine,"Stimulant",Treatment of ADHD and obesity (rarely used),"Insomnia, tachycardia, hypertension",Extremely high potential for abuse.
Y11,Methimazole,"Thionamide",Treatment of hyperthyroidism,"Rash, agranulocytosis (rare), hepatotoxicity",N/A
Z11,Methocarbamol,"Muscle relaxant",Relief of musculoskeletal pain and spasms,"Drowsiness, dizziness",N/A
AA1,Methotrexate,"Antimetabolite/Antirheumatic",Treatment of cancers, psoriasis, and rheumatoid arthritis,"Myelosuppression, hepatotoxicity, pulmonary toxicity",Dosing frequency varies by indication (e.g., weekly for RA, daily for cancer).
BB1,Methylcellulose,Bulk-forming laxative,Treatment of constipation,"Bloating, flatulence",Take with plenty of water.
CC1,Methyldopa,"Alpha-2 adrenergic agonist (central)",Treatment of hypertension, particularly in pregnancy,"Drowsiness, orthostatic hypotension, positive Coombs' test",N/A
DD1,Methylergonovine,"Ergot alkaloid",Prevention and treatment of postpartum hemorrhage,"Hypertension, headache, seizures",N/A
EE1,Methylphenidate,"Stimulant",Treatment of ADHD and narcolepsy,"Insomnia, decreased appetite, nervousness",Potential for abuse and dependence.
FF1,Methylprednisolone,"Corticosteroid",Treatment of inflammatory and autoimmune conditions,"Many side effects with systemic use",N/A
GG1,Metoclopramide,"Dopamine antagonist",Treatment of gastroparesis and prevention of nausea/vomiting,"Drowsiness, extrapyramidal symptoms, tardive dyskinesia (boxed warning)",N/A
HH1,Metoprolol,"Beta-blocker (cardioselective)",Treatment of hypertension, angina, and heart failure,"Fatigue, dizziness, bradycardia",Available as tartrate (immediate-release) and succinate (extended-release).
II1,Metronidazole,"Nitroimidazole antibiotic/antiprotozoal",Treatment of anaerobic and protozoal infections,"Metallic taste, nausea, disulfiram-like reaction with alcohol",Avoid alcohol during and for 3 days after treatment.
JJ1,Miconazole,"Azole antifungal",Topical treatment of fungal infections,"Burning, itching, irritation",Available in many topical formulations (cream, powder, vaginal).
KK1,Midazolam,"Benzodiazepine",Sedation, anxiolysis, amnesia before medical procedures,"Respiratory depression, hypotension",Administered IV, IM, or intranasally.
LL1,Midodrine,"Alpha-1 agonist",Treatment of orthostatic hypotension,"Supine hypertension, paresthesias, pruritus",Should not be taken after the evening meal or before bedtime.
MM1,Miglustat,"Glucosylceramide synthase inhibitor",Treatment of Gaucher disease type 1,"Diarrhea, weight loss, tremor",N/A
NN1,Milnacipran,"SNRI antidepressant",Treatment of fibromyalgia,"Nausea, headache, insomnia",Not approved for depression in the US.
OO1,Milrinone,"Phosphodiesterase-3 inhibitor",Short-term IV treatment of acute decompensated heart failure,"Ventricular arrhythmias, hypotension",N/A
PP1,Minocycline,"Tetracycline antibiotic",Treatment of acne and various bacterial infections,"Dizziness, photosensitivity, drug-induced lupus",Can cause bluish-gray skin discoloration.
QQ1,Minoxidil,"Vasodilator/Hair growth stimulant",Treatment of hypertension (oral); treatment of androgenetic alopecia (topical),"Reflex tachycardia, fluid retention (oral); scalp itching, unwanted hair growth (topical)",N/A
RR1,Mirtazapine,"Atypical antidepressant",Treatment of depression,"Sedation, increased appetite, weight gain",Often used for depression with insomnia or low appetite.
SS1,Mirabegron,"Beta-3 adrenergic agonist",Treatment of overactive bladder (OAB),"Hypertension, nasopharyngitis, UTI",Can increase blood pressure.
TT1,Mitomycin,"Antitumor antibiotic",Treatment of various cancers,"Myelosuppression, hemolytic uremic syndrome",Vesicant; can cause severe tissue damage if it extravasates.
UU1,Mitoxantrone,"Anthracenedione",Treatment of multiple sclerosis and certain cancers,"Cardiotoxicity, myelosuppression, blue-green discoloration of urine/sclera",N/A
VV1,Modafinil,"Wakefulness-promoting agent",Treatment of narcolepsy, sleep apnea, and shift work sleep disorder,"Headache, nausea, anxiety","Serious rash (Stevens-Johnson Syndrome)"
WW1,Mometasone,"Corticosteroid",Topical, nasal, and inhaled use for skin conditions, rhinitis, and asthma,"Nasal irritation, headache, pharyngitis",N/A
XX1,Montelukast,"Leukotriene receptor antagonist",Treatment of asthma and allergic rhinitis,"Headache, neuropsychiatric events (boxed warning)",Monitor for behavior and mood-related changes.
YY1,Morphine,"Opioid analgesic",Management of severe pain,"Respiratory depression, constipation, sedation",The standard against which other opioids are compared.
ZZ1,Moxifloxacin,"Fluoroquinolone antibiotic",Treatment of bacterial infections,"Nausea, diarrhea, QT prolongation",Risk of tendinitis and tendon rupture.
A12,Mupirocin,"Antibiotic",Topical treatment of impetigo and to eradicate nasal colonization with MRSA,"Burning, stinging, itching at application site",N/A
B12,Mycophenolate,"Immunosuppressant",Prevention of organ transplant rejection,"Diarrhea, leukopenia, increased risk of infections","Increased risk of birth defects and miscarriage (boxed warning)"
C12,Nabumetone,"NSAID",Relief of pain and inflammation,"GI upset, increased risk of cardiovascular events",Prodrug.
D12,Nadolol,"Beta-blocker (non-selective)",Treatment of hypertension and angina,"Bradycardia, fatigue, bronchospasm",Long half-life.
E12,Nafcillin,"Penicillinase-resistant penicillin",Treatment of infections caused by penicillinase-producing staphylococci,"Rash, interstitial nephritis",Administered IV.
F12,Nalbuphine,"Opioid agonist-antagonist",Relief of moderate to severe pain,"Sedation, nausea, sweating",Has a ceiling effect for respiratory depression.
G12,Naloxone,"Opioid antagonist",Reversal of opioid overdose,"Opioid withdrawal symptoms in dependent individuals",Available as injectable and nasal spray.
H12,Naltrexone,"Opioid antagonist",Treatment of alcohol and opioid dependence,"Nausea, headache, hepatotoxicity",Patient must be opioid-free before starting.
I12,Naproxen,"NSAID",Relief of pain, fever, and inflammation,"GI upset, increased risk of cardiovascular events and GI bleeding",Available over-the-counter and by prescription.
J12,Naratriptan,"5-HT1 receptor agonist (triptan)",Acute treatment of migraine,"Dizziness, fatigue, paresthesias",Slower onset and better tolerated than sumatriptan.
K12,Natalizumab,"Integrin receptor antagonist",Treatment of multiple sclerosis and Crohn's disease,"Progressive multifocal leukoencephalopathy (PML) (boxed warning), infusion reactions",Available only through a restricted distribution program.
L12,Nateglinide,"Meglitinide",Improves glycemic control in type 2 diabetes,"Hypoglycemia, upper respiratory infection",Take before meals.
M12,Nedocromil,"Mast cell stabilizer",Maintenance therapy for mild to moderate asthma,"Unpleasant taste, headache, cough",Less commonly used now.
N12,Nelarabine,"Antineoplastic agent",Treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma,"Neurotoxicity, myelosuppression",N/A
O12,Nelfinavir,"Protease inhibitor",Treatment of HIV infection,"Diarrhea",No longer a preferred agent.
P12,Neomycin,"Aminoglycoside antibiotic",Topical use for skin infections; oral use for bowel decontamination,"Ototoxicity and nephrotoxicity with systemic absorption, contact dermatitis",N/A
Q12,Nepafenac,"NSAID",Ophthalmic treatment of pain and inflammation associated with cataract surgery,"Delayed wound healing, foreign body sensation",N/A
R12,Neratinib,"Kinase inhibitor",Extended adjuvant treatment of HER2-positive breast cancer,"Severe diarrhea, hepatotoxicity",Prophylaxis for diarrhea is recommended.
S12,Netilmicin,Aminoglycoside antibiotic,Treatment of serious bacterial infections,"Nephrotoxicity, ototoxicity",Less commonly used.
T12,Nevirapine,"NNRTI",Treatment of HIV-1 infection,"Severe hepatotoxicity and skin reactions (boxed warning)",Requires a 14-day lead-in period to reduce rash risk.
U12,Niacin (Vitamin B3),Lipid-lowering agent/Vitamin,Lowers triglycerides and LDL, raises HDL; treats niacin deficiency,"Flushing, itching, GI upset",Flushing can be reduced by taking aspirin 30 minutes prior.
V12,Nicardipine,"Calcium channel blocker",Treatment of hypertension and angina,"Headache, flushing, edema",Available as IV for hypertensive emergencies.
W12,Nicotine,Stimulant/Smoking cessation aid,Relief of nicotine withdrawal symptoms,"Tachycardia, nausea, local irritation (depending on formulation)",Available as gum, patch, lozenge, inhaler, nasal spray.
X12,Nifedipine,"Calcium channel blocker",Treatment of hypertension and angina,"Peripheral edema, flushing, gingival hyperplasia",Short-acting formulations can cause profound hypotension and are generally avoided.
Y12,Nilotinib,"Kinase inhibitor (BCR-ABL inhibitor)",Treatment of chronic myeloid leukemia (CML),"QT prolongation (boxed warning), myelosuppression, elevated lipase",Take on an empty stomach.
Z12,Nilutamide,"Androgen receptor inhibitor",Treatment of metastatic prostate cancer (with surgical castration),"Delayed adaptation to darkness, interstitial pneumonitis, hepatotoxicity",N/A
A13,Nimodipine,"Calcium channel blocker",Improves neurological outcome after subarachnoid hemorrhage,"Hypotension",Specifically for cerebral vasospasm; do not administer IV.
B13,Nintedanib,"Kinase inhibitor",Treatment of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases,"Diarrhea, nausea, elevated liver enzymes",N/A
C13,Niraparib,"PARP inhibitor",Maintenance treatment of ovarian cancer and other cancers,"Myelosuppression, hypertension, fatigue",N/A
D13,Nisoldipine,"Calcium channel blocker",Treatment of hypertension,"Peripheral edema, headache, flushing",N/A
E13,Nitazoxanide,"Antiprotozoal",Treatment of diarrhea caused by Giardia or Cryptosporidium,"Abdominal pain, headache, nausea",N/A
F13,Nitrofurantoin,"Antibiotic",Treatment and prevention of urinary tract infections (UTIs),"Nausea, pulmonary reactions (acute and chronic), hepatotoxicity",Contraindicated in severe renal impairment (CrCl < 60 mL/min).
G13,Nitroglycerin,"Nitrate vasodilator",Treatment and prevention of angina pectoris,"Headache, hypotension, dizziness",Tolerance can develop with continuous use.
H13,Norepinephrine,"Adrenergic agonist",Treatment of shock and severe hypotension,"Hypertension, arrhythmias, peripheral ischemia",Potent vasoconstrictor.
I13,Norelgestromin,"Progestin",Component of a combination contraceptive patch,"Application site reactions, breast tenderness, headache",N/A
J13,Norethindrone,"Progestin",Used in oral contraceptives and for treatment of abnormal uterine bleeding,"Irregular bleeding, headache",N/A
K13,Nortriptyline,"Tricyclic antidepressant",Treatment of depression,"Drowsiness, dry mouth, constipation",Metabolite of amitriptyline.
L13,Nystatin,"Antifungal",Treatment of Candida infections (oral, skin, vaginal),"Nausea (oral use); local irritation",Not absorbed from the GI tract.
M13,Ofatumumab,"Anti-CD20 monoclonal antibody",Treatment of chronic lymphocytic leukemia (CLL) and multiple sclerosis,"Infusion reactions, myelosuppression, increased risk of infections",N/A
N13,Ofloxacin,"Fluoroquinolone antibiotic",Treatment of various bacterial infections; ophthalmic and otic use,"Nausea, photosensitivity, tendinitis risk",N/A
O13,Olanzapine,"Atypical antipsychotic",Treatment of schizophrenia and bipolar disorder,"Weight gain, somnolence, metabolic changes (hyperglycemia, hyperlipidemia)",Risk of post-injection delirium/sedation syndrome with long-acting injection.
P13,Olaparib,"PARP inhibitor",Treatment of ovarian, breast, and other cancers with BRCA mutations,"Anemia, fatigue, nausea",N/A
Q13,Olmesartan,"Angiotensin II receptor blocker (ARB)",Treatment of hypertension,"Dizziness, risk of sprue-like enteropathy",Avoid in pregnancy.
R13,Olodaterol,"Long-acting beta-2 agonist (LABA)",Long-term maintenance treatment of COPD,"Nasopharyngitis, cough",Inhaled once daily.
S13,Oloratadine,N/A,N/A,N/A,N/A
T13,Omacetaxine,"Protein synthesis inhibitor",Treatment of chronic myeloid leukemia (CML) when resistant to other therapies,"Myelosuppression, bleeding, hyperglycemia",N/A
U13,Omalizumab,"Anti-IgE monoclonal antibody",Treatment of moderate to severe allergic asthma and chronic idiopathic urticaria,"Anaphylaxis (boxed warning), injection site reactions, headache",Administered subcutaneously.
V13,Ombitasvir/paritaprevir/ritonavir,Direct-acting antiviral combination,Treatment of chronic hepatitis C (used with or without dasabuvir),"Fatigue, nausea, risk of hepatic decompensation",Complex regimen with multiple drug interactions.
W13,Omeprazole,"Proton pump inhibitor (PPI)",Treatment of GERD, ulcers, and Zollinger-Ellison syndrome,"Headache, diarrhea, abdominal pain",Available over-the-counter and by prescription.
X13,Ondansetron,"5-HT3 receptor antagonist",Prevention of nausea and vomiting,"Headache, constipation, QT prolongation",N/A
Y13,Oritavancin,"Lipoglycopeptide antibiotic",Treatment of acute bacterial skin and skin structure infections (ABSSSI),"Nausea, headache, infusion reactions",Single-dose IV infusion.
Z13,Orlistat,"Lipase inhibitor",Weight loss agent,"Oily spotting, flatus with discharge, fecal urgency",Interferes with absorption of fat-soluble vitamins.
A14,Oseltamivir,"Neuraminidase inhibitor",Treatment and prevention of influenza,"Nausea, vomiting, headache",Most effective when started within 48 hours of symptom onset.
B14,Osimertinib,"Kinase inhibitor (EGFR inhibitor)",Treatment of EGFR-mutated non-small cell lung cancer,"Diarrhea, rash, cardiotoxicity",Effective against T790M resistance mutation.
C14,Oxacillin,"Penicillinase-resistant penicillin",Treatment of infections caused by penicillinase-producing staphylococci,"Rash, diarrhea",Administered IV.
D14,Oxaliplatin,"Platinum-based chemotherapy",Treatment of colorectal cancer,"Peripheral neuropathy (can be acute and cold-induced), myelosuppression",N/A
E14,Oxandrolone,"Anabolic steroid",Promote weight gain after surgery or chronic infection,"Hepatotoxicity, virilization in females",Controlled substance.
F14,Oxaprozin,"NSAID",Relief of pain and inflammation, particularly for arthritis,"GI upset, photosensitivity",Long half-life.
G14,Oxazepam,"Benzodiazepine",Management of anxiety and alcohol withdrawal,"Drowsiness, dizziness",Metabolized by conjugation, so safer in liver disease than some other benzodiazepines.
H14,Oxcarbazepine,"Anticonvulsant",Treatment of partial-onset seizures,"Dizziness, somnolence, hyponatremia",Chemically related to carbamazepine but with a better side effect profile for some.
I14,Oxybutynin,"Anticholinergic",Treatment of overactive bladder (OAB),"Dry mouth, constipation, drowsiness",Available as oral and transdermal patch.
J14,Oxycodone,"Opioid analgesic",Relief of moderate to severe pain,"Constipation, nausea, sedation, respiratory depression",High potential for abuse.
K14,Oxymetazoline,"Adrenergic agonist (vasoconstrictor)",Nasal decongestant,"Rebound congestion with prolonged use, nasal stinging",Should not be used for more than 3 days.
L14,Oxymorphone,"Opioid analgesic",Management of severe pain,"Respiratory depression, sedation, constipation",More potent than morphine.
M14,Paclitaxel,"Taxane",Treatment of various cancers, including ovarian, breast, and lung cancer,"Myelosuppression, peripheral neuropathy, hypersensitivity reactions",Requires premedication to prevent hypersensitivity. Some formulations are albumin-bound (nab-paclitaxel).
N14,Palbociclib,"CDK4/6 inhibitor",Treatment of HR-positive, HER2-negative breast cancer (with an aromatase inhibitor or fulvestrant),"Neutropenia, fatigue, nausea",Monitor blood counts.
O14,Paliperidone,"Atypical antipsychotic",Treatment of schizophrenia and schizoaffective disorder,"Extrapyramidal symptoms, hyperprolactinemia, somnolence",Active metabolite of risperidone; available as long-acting injection.
P14,Palonosetron,"5-HT3 receptor antagonist",Prevention of chemotherapy-induced nausea and vomiting,"Headache, constipation",Longer half-life than other agents in its class.
Q14,Pamidronate,"Bisphosphonate",Treatment of hypercalcemia of malignancy and bone metastases,"Fever, flu-like symptoms, hypocalcemia",Administered by IV infusion.
R14,Pancrelipase,"Pancreatic enzymes",Replacement therapy for pancreatic exocrine insufficiency (e.g., in cystic fibrosis),"Abdominal pain, flatulence, fibrosing colonopathy (high doses)",Take with meals.
S14,Panitumumab,"EGFR inhibitor",Treatment of RAS wild-type metastatic colorectal cancer,"Dermatologic toxicities (rash), infusion reactions",N/A
T14,Panobinostat,"Histone deacetylase (HDAC) inhibitor",Treatment of multiple myeloma (in combination with bortezomib and dexamethasone),"Severe diarrhea and cardiac events (boxed warnings), myelosuppression",Monitor ECG and electrolytes.
U14,Pantoprazole,"Proton pump inhibitor (PPI)",Treatment of GERD and ulcers,"Headache, diarrhea",N/A
V14,Paroxetine,"SSRI antidepressant",Treatment of depression, anxiety disorders, and OCD,"Nausea, drowsiness, sexual dysfunction",Potent inhibitor of CYP2D6; can have more withdrawal symptoms.
W14,Pasireotide,"Somatostatin analog",Treatment of Cushing's disease and acromegaly,"Hyperglycemia, diarrhea, nausea",More potent than octreotide at inhibiting ACTH.
X14,Pazopanib,"Kinase inhibitor",Treatment of renal cell carcinoma and soft tissue sarcoma,"Hepatotoxicity (boxed warning), hypertension, diarrhea",N/A
Y14,Pegfilgrastim,"Long-acting G-CSF",Prophylaxis of chemotherapy-induced neutropenia,"Bone pain",Single injection per chemotherapy cycle.
Z14,Peginterferon alfa,"Pegylated interferon",Treatment of chronic hepatitis B and C,"Flu-like symptoms, depression, myelosuppression",Longer half-life than standard interferon.
A15,Pemetrexed,"Folate antimetabolite",Treatment of mesothelioma and non-small cell lung cancer,"Myelosuppression, rash, fatigue",Supplement with folic acid and vitamin B12 to reduce toxicity.
B15,Pemoline,"Stimulant",Treatment of ADHD (largely discontinued),"Hepatotoxicity (boxed warning), insomnia, anorexia",Use has been restricted due to liver toxicity.
C15,Penicillamine,"Chelating agent",Treatment of Wilson's disease, rheumatoid arthritis, and cystinuria,"Myelosuppression, autoimmune diseases, rash",N/A
D15,Penicillin G,Penicillin antibiotic,Treatment of various bacterial infections, especially syphilis,"Allergic reactions",The prototypical penicillin.
E15,Penicillin V,Penicillin antibiotic,Treatment of various bacterial infections, e.g., strep throat,"Allergic reactions, GI upset",Oral formulation of penicillin.
F15,Pentamidine,"Antiprotozoal",Treatment and prevention of Pneumocystis jirovecii pneumonia (PJP),"Nephrotoxicity, hypotension, pancreatitis",Administered IV or by inhalation.
G15,Pentobarbital,"Barbiturate",Treatment of seizures, pre-operative sedation, and induction of coma for cerebral edema,"Respiratory depression, hypotension, dependence",Controlled substance.
H15,Pentosan polysulfate,"Heparinoid",Relief of bladder pain or discomfort associated with interstitial cystitis,"Alopecia, diarrhea, nausea",Risk of pigmentary maculopathy with long-term use.
I15,Pentoxifylline,"Hemorheologic agent",Treatment of intermittent claudication,"Nausea, dizziness",Improves blood flow by decreasing blood viscosity.
J15,Perampanel,"AMPA receptor antagonist",Adjunctive treatment of partial-onset seizures and primary generalized tonic-clonic seizures,"Serious psychiatric and behavioral reactions (boxed warning), dizziness, somnolence",N/A
K15,Perindopril,"ACE inhibitor",Treatment of hypertension and stable coronary artery disease,"Cough, dizziness",N/A
L15,Perphenazine,"Typical antipsychotic",Treatment of schizophrenia,"Extrapyramidal symptoms, sedation",N/A
M15,Pertuzumab,"HER2 dimerization inhibitor",Treatment of HER2-positive breast cancer (in combination with trastuzumab and chemotherapy),"Diarrhea, neutropenia, cardiotoxicity",N/A
N15,Phenelzine,"MAO inhibitor (non-selective)",Treatment of depression,"Orthostatic hypotension, dizziness, hypertensive crisis with tyramine-rich foods",Many food and drug interactions.
O15,Phenobarbital,"Barbiturate",Treatment of various seizure disorders,"Sedation, cognitive impairment, dependence",Inducer of many CYP enzymes.
P15,Phenoxybenzamine,"Alpha-blocker (non-selective, irreversible)",Management of pheochromocytoma,"Orthostatic hypotension, reflex tachycardia, nasal congestion",N/A
Q15,Phentermine,"Sympathomimetic amine (appetite suppressant)",Short-term management of obesity,"Tachycardia, hypertension, insomnia",Controlled substance.
R15,Phentolamine,"Alpha-blocker (non-selective, reversible)",Diagnosis and treatment of pheochromocytoma; reversal of soft tissue anesthesia,"Hypotension, tachycardia",N/A
S15,Phenylephrine,"Alpha-1 adrenergic agonist",Nasal decongestant (oral, nasal) and vasopressor (IV),"Hypertension, reflex bradycardia, anxiety",N/A
T15,Phenytoin,"Anticonvulsant",Treatment of various seizure disorders,"Gingival hyperplasia, hirsutism, nystagmus",Non-linear kinetics; requires therapeutic drug monitoring.
U15,Pioglitazone,"Thiazolidinedione (TZD)",Improves glycemic control in type 2 diabetes,"Edema, weight gain, increased risk of bladder cancer and fractures",Can exacerbate heart failure (boxed warning).
V15,Piperacillin/tazobactam,Penicillin antibiotic + beta-lactamase inhibitor,Treatment of moderate to severe bacterial infections,"Diarrhea, rash, nausea",Broad-spectrum antibiotic.
W15,Pirfenidone,"Antifibrotic agent",Treatment of idiopathic pulmonary fibrosis (IPF),"Rash, nausea, hepatotoxicity",Take with food.
X15,Piroxicam,"NSAID",Relief of pain and inflammation,"High risk of GI bleeding and skin reactions",Long half-life.
Y15,Pomalidomide,"Immunomodulatory agent",Treatment of multiple myeloma,"Thromboembolism, myelosuppression, severe birth defects (boxed warning)",Similar to thalidomide and lenalidomide; requires REMS program.
Z15,Ponatinib,"Kinase inhibitor",Treatment of CML and Ph+ ALL resistant to other therapies,"Arterial and venous thrombosis and occlusions (boxed warning), hepatotoxicity",Indicated for patients with the T315I mutation.
AA2,Posaconazole,"Azole antifungal",Prophylaxis and treatment of invasive fungal infections,"Nausea, QT prolongation, hepatotoxicity",Absorption is improved with a high-fat meal.
BB2,Pramipexole,"Dopamine agonist",Treatment of Parkinson's disease and restless legs syndrome,"Somnolence (including sudden sleep attacks), nausea, hallucinations",N/A
CC2,Pramlintide,"Amylin analog",Adjunctive treatment for type 1 and type 2 diabetes,"Severe hypoglycemia (when used with insulin; boxed warning), nausea",Administered subcutaneously before meals.
DD2,Prasugrel,"Antiplatelet agent",Reduces thrombotic events in patients with acute coronary syndrome undergoing PCI,"Bleeding (higher risk than clopidogrel; boxed warning)",Contraindicated in patients with a history of stroke or TIA.
EE2,Pravastatin,"HMG-CoA reductase inhibitor (statin)",Lowers high cholesterol levels,"Generally well-tolerated; myopathy risk exists",Less likely to have drug interactions via CYP enzymes.
FF2,Praziquantel,"Anthelmintic",Treatment of schistosome and liver fluke infections,"Dizziness, headache, nausea",N/A
GG2,Prazosin,"Alpha-1 blocker",Treatment of hypertension,"First-dose syncope, dizziness",Also used off-label for PTSD-related nightmares.
HH2,Prednisolone,"Corticosteroid",Treatment of inflammatory and autoimmune conditions,"Many side effects with systemic use",N/A
II2,Prednisone,"Corticosteroid",Treatment of inflammatory and autoimmune conditions,"Many side effects with systemic use",Prodrug converted to prednisolone in the liver.
JJ2,Pregabalin,"Anticonvulsant/Neuropathic pain agent",Treatment of neuropathic pain, fibromyalgia, and seizures,"Dizziness, somnolence, peripheral edema",Controlled substance.
KK2,Probenecid,"Uricosuric agent",Treatment of gout; increases levels of some antibiotics (e.g., penicillin),"GI upset, rash",Do not start during an acute gout attack.
LL2,Procarbazine,"Alkylating agent",Treatment of Hodgkin lymphoma,"Myelosuppression, nausea, secondary malignancies",Weak MAO inhibitor; has food and drug interactions.
MM2,Prochlorperazine,"Typical antipsychotic/antiemetic",Treatment of severe nausea and vomiting; anxiety and schizophrenia,"Sedation, extrapyramidal symptoms",N/A
NN2,Promethazine,"Antihistamine/antiemetic",Treatment of nausea, allergies, and motion sickness; sedative,"Profound sedation, respiratory depression (boxed warning in children <2)",N/A
OO2,Propafenone,"Antiarrhythmic",Prevention of various arrhythmias,"Dizziness, unusual taste, proarrhythmic effects",Has beta-blocking activity.
PP2,Propranolol,"Beta-blocker (non-selective)",Treatment of hypertension, angina, arrhythmias, and migraine prophylaxis,"Bradycardia, fatigue, bronchospasm",Used for performance anxiety.
QQ2,Propylthiouracil (PTU),"Thionamide",Treatment of hyperthyroidism,"Severe liver injury (boxed warning), rash, agranulocytosis",Preferred agent in the 1st trimester of pregnancy, but methimazole is preferred otherwise.
RR2,Protamine,Antidote,Reversal of heparin anticoagulation,"Hypotension, anaphylactoid reactions",N/A
SS2,Protriptyline,"Tricyclic antidepressant",Treatment of depression,"Activating (can cause insomnia), dry mouth, constipation",N/A
TT2,Pseudoephedrine,"Decongestant",Relief of nasal congestion,"Tachycardia, insomnia, nervousness",Regulated due to its use in the illicit manufacture of methamphetamine.
UU2,Psyllium,Bulk-forming laxative,Treatment of constipation,"Bloating, flatulence",Take with plenty of water.
VV2,Pyrazinamide,"Antimycobacterial",Treatment of tuberculosis (part of a multi-drug regimen),"Hepatotoxicity, hyperuricemia",N/A
WW2,Pyridostigmine,"Cholinesterase inhibitor",Treatment of myasthenia gravis,"Salivation, lacrimation, urination, defecation, GI distress (SLUDGE effects)",N/A
XX2,Quetiapine,"Atypical antipsychotic",Treatment of schizophrenia, bipolar disorder, and as an adjunct for depression,"Somnolence, weight gain, metabolic changes",N/A
YY2,Quinapril,"ACE inhibitor",Treatment of hypertension and heart failure,"Cough, dizziness",N/A
ZZ2,Quinidine,"Antiarrhythmic",Treatment of malaria and arrhythmias,"Diarrhea, tinnitus (cinchonism), proarrhythmic effects",Many drug interactions.
A16,Quinine,"Antimalarial",Treatment of uncomplicated malaria,"Cinchonism (tinnitus, headache, dizziness), hemolytic anemia in G6PD deficiency",No longer recommended for leg cramps.
B16,Raltegravir,"Integrase inhibitor",Treatment of HIV-1 infection,"Nausea, headache, elevated CPK",N/A
C16,Ramipril,"ACE inhibitor",Treatment of hypertension and heart failure,"Cough, dizziness",N/A
D16,Ranitidine,"H2 receptor antagonist",Treatment of heartburn and ulcers,"Headache, constipation",Largely withdrawn from the market due to contamination with NDMA.
E16,Ranolazine,"Late sodium current inhibitor",Treatment of chronic angina,"Dizziness, headache, constipation",Prolongs the QT interval.
F16,Rasagiline,"MAO-B inhibitor",Treatment of Parkinson's disease,"Headache, arthralgia",N/A
G16,Reboxetine,Norepinephrine reuptake inhibitor,Treatment of depression (not available in the US),"Insomnia, dry mouth, constipation",N/A
H16,Regorafenib,"Kinase inhibitor",Treatment of colorectal cancer, GIST, and hepatocellular carcinoma,"Hand-foot skin reaction, hepatotoxicity (boxed warning), fatigue",N/A
I16,Relugolix,"GnRH antagonist",Treatment of advanced prostate cancer and uterine fibroids,"Hot flashes, fatigue",Oral GnRH antagonist.
J16,Remdesivir,"Antiviral",Treatment of COVID-19,"Nausea, elevated liver enzymes",Administered IV.
K16,Repaglinide,"Meglitinide",Improves glycemic control in type 2 diabetes,"Hypoglycemia, upper respiratory infection",Take before meals.
L16,Reserpine,"Adrenergic depleting agent",Treatment of hypertension (rarely used),"Depression, sedation, nasal congestion",N/A
M16,Retapamulin,"Pleuromutilin antibiotic",Topical treatment of impetigo,"Application site irritation",N/A
N16,Retigabine (Ezogabine),"Potassium channel opener",Adjunctive treatment of partial-onset seizures,"Retinal abnormalities and skin discoloration (boxed warnings), dizziness, somnolence",Withdrawn from the market.
O16,Ribavirin,"Antiviral",Treatment of chronic hepatitis C and other viral infections,"Hemolytic anemia (boxed warning), teratogenic (boxed warning)",Contraindicated in pregnancy and male partners of pregnant women.
P16,Ribociclib,"CDK4/6 inhibitor",Treatment of HR-positive, HER2-negative breast cancer,"Neutropenia, QT prolongation, hepatotoxicity",Monitor ECG, electrolytes, and liver function.
Q16,Rifabutin,"Rifamycin",Prevention of MAC disease in AIDS patients; treatment of tuberculosis,"Rash, neutropenia, uveitis",Inducer of CYP3A4, but less potent than rifampin.
R16,Rifampin (Rifampicin),"Rifamycin",Treatment of tuberculosis, leprosy, and other infections,"Hepatotoxicity, red-orange discoloration of body fluids",Potent inducer of many CYP enzymes, leading to numerous drug interactions.
S16,Rifaximin,"Rifamycin antibiotic",Treatment of traveler's diarrhea, IBS-D, and reduction of hepatic encephalopathy recurrence,"Peripheral edema, dizziness, nausea",Minimally absorbed systemically.
T16,Rilonacept,"Interleukin-1 blocker",Treatment of cryopyrin-associated periodic syndromes (CAPS),"Injection site reactions, upper respiratory tract infections",N/A
U16,Rilpivirine,"NNRTI",Treatment of HIV-1 infection,"Depressive disorders, insomnia, headache",Requires an acidic environment for absorption; contraindicated with PPIs.
V16,Riociguat,"Soluble guanylate cyclase stimulator",Treatment of pulmonary arterial hypertension (PAH) and CTEPH,"Hypotension, headache, dizziness","Pregnancy (boxed warning)"
W16,Risedronate,"Bisphosphonate",Treatment and prevention of osteoporosis,"Esophagitis, musculoskeletal pain",Requires specific administration instructions (e.g., stay upright).
X16,Risperidone,"Atypical antipsychotic",Treatment of schizophrenia and bipolar disorder,"Extrapyramidal symptoms, hyperprolactinemia, weight gain",Available as a long-acting injection.
Y16,Ritonavir,"Protease inhibitor/Pharmacokinetic enhancer",Treatment of HIV infection (primarily as a booster for other PIs),"GI intolerance, hyperlipidemia",Potent inhibitor of CYP3A4.
Z16,Rituximab,"Anti-CD20 monoclonal antibody",Treatment of non-Hodgkin's lymphoma, CLL, and rheumatoid arthritis,"Infusion reactions, severe mucocutaneous reactions, PML (boxed warnings)",N/A
AA3,Rivaroxaban,"Factor Xa inhibitor",Prevention and treatment of blood clots,"Bleeding",Doses > 15mg should be taken with food.
BB3,Rivastigmine,"Cholinesterase inhibitor",Treatment of Alzheimer's and Parkinson's disease dementia,"Nausea, vomiting, diarrhea",Available as a transdermal patch which has better GI tolerability.
CC3,Rizatriptan,"5-HT1 receptor agonist (triptan)",Acute treatment of migraine,"Dizziness, somnolence, chest tightness",Available as oral disintegrating tablet.
DD3,Rocuronium,"Nondepolarizing neuromuscular blocker",Skeletal muscle relaxation during surgery or mechanical ventilation,"Transient hypotension or hypertension",Antidote is sugammadex.
EE3,Roflumilast,"Phosphodiesterase-4 inhibitor",Reduces COPD exacerbations,"Diarrhea, weight loss, nausea",Associated with psychiatric events.
FF3,Romidepsin,"Histone deacetylase (HDAC) inhibitor",Treatment of cutaneous and peripheral T-cell lymphoma,"Myelosuppression, QT prolongation, infections",N/A
GG3,Ropinirole,"Dopamine agonist",Treatment of Parkinson's disease and restless legs syndrome,"Somnolence (including sudden sleep attacks), nausea, orthostatic hypotension",N/A
HH3,Ropivacaine,"Local anesthetic",Surgical anesthesia and pain management,"Hypotension, nausea",Similar to bupivacaine, possibly less cardiotoxic.
II3,Rosiglitazone,"Thiazolidinedione (TZD)",Improves glycemic control in type 2 diabetes,"Edema, increased risk of heart failure (boxed warning), fractures",Use is highly restricted due to cardiovascular concerns.
JJ3,Rosuvastatin,"HMG-CoA reductase inhibitor (statin)",Lowers high cholesterol levels,"Myopathy, hepatotoxicity",Potent statin.
KK3,Rufinamide,"Anticonvulsant",Adjunctive treatment of seizures associated with Lennox-Gastaut syndrome,"Somnolence, vomiting, headache",Shortens the QT interval.
LL3,Ruxolitinib,"JAK inhibitor",Treatment of myelofibrosis and polycythemia vera,"Thrombocytopenia, anemia, bruising",N/A
MM3,Sacubitril/valsartan,"Neprilysin inhibitor/ARB",Treatment of heart failure with reduced ejection fraction,"Hypotension, hyperkalemia, cough",Do not administer with or within 36 hours of an ACE inhibitor.
NN3,Salmeterol,"Long-acting beta-2 agonist (LABA)",Treatment of asthma and COPD (always with an inhaled corticosteroid in asthma),"Increased risk of asthma-related death when used as monotherapy in asthma (boxed warning), tremor",N/A
OO3,Sapropterin,"Synthetic BH4",Reduces blood phenylalanine levels in patients with phenylketonuria (PKU),"Headache, rhinorrhea",N/A
PP3,Saquinavir,"Protease inhibitor",Treatment of HIV infection (with ritonavir),"Nausea, diarrhea, QT prolongation",Must be boosted with ritonavir.
QQ3,Sarilumab,"IL-6 receptor antagonist",Treatment of rheumatoid arthritis,"Neutropenia, increased ALT, injection site erythema",N/A
RR3,Saxagliptin,"DPP-4 inhibitor",Improves glycemic control in type 2 diabetes,"Upper respiratory tract infection, headache, increased risk of heart failure hospitalization",N/A
SS3,Scopolamine,"Anticholinergic",Prevention of motion sickness and postoperative nausea/vomiting,"Dry mouth, drowsiness, blurred vision",Available as a transdermal patch.
TT3,Secobarbital,"Barbiturate",Short-term treatment of insomnia, pre-operative sedation,"Respiratory depression, dependence",Controlled substance.
UU3,Secukinumab,"IL-17A antagonist",Treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis,"Nasopharyngitis, increased risk of infections",N/A
VV3,Selexipag,"IP prostacyclin receptor agonist",Treatment of pulmonary arterial hypertension (PAH),"Headache, diarrhea, jaw pain",Active metabolite has greater potency.
WW3,Selinexor,"Selective inhibitor of nuclear export (SINE)",Treatment of multiple myeloma and diffuse large B-cell lymphoma,"Thrombocytopenia, nausea, fatigue",N/A
XX3,Sertraline,"SSRI antidepressant",Treatment of depression, OCD, panic disorder, and PTSD,"Nausea, diarrhea, insomnia",N/A
YY3,Sevelamer,"Phosphate binder",Controls phosphorus levels in patients with chronic kidney disease on dialysis,"Nausea, vomiting, diarrhea",Take with meals.
ZZ3,Sildenafil,"PDE-5 inhibitor",Treatment of erectile dysfunction and pulmonary arterial hypertension,"Headache, flushing, visual disturbances",Contraindicated with nitrates.
A17,Silodosin,"Alpha-1A blocker",Treatment of benign prostatic hyperplasia (BPH),"Retrograde ejaculation, dizziness, orthostatic hypotension",N/A
B17,Siltuximab,"IL-6 antagonist",Treatment of multicentric Castleman's disease,"Pruritus, rash, upper respiratory tract infection",N/A
C17,Simeprevir,"HCV protease inhibitor",Treatment of chronic hepatitis C,"Photosensitivity, rash, nausea",No longer recommended as a preferred therapy.
D17,Simvastatin,"HMG-CoA reductase inhibitor (statin)",Lowers high cholesterol levels,"Myopathy, hepatotoxicity",Increased risk of myopathy at 80mg dose; many drug interactions via CYP3A4.
E17,Siponimod,"Sphingosine 1-phosphate receptor modulator",Treatment of secondary progressive multiple sclerosis (SPMS),"Headache, hypertension, liver function test elevation",Requires CYP2C9 genotyping before use.
F17,Sirolimus,"mTOR inhibitor",Prevention of organ transplant rejection; treatment of lymphangioleiomyomatosis,"Myelosuppression, hyperlipidemia, mouth ulcers",Requires therapeutic drug monitoring.
G17,Sitagliptin,"DPP-4 inhibitor",Improves glycemic control in type 2 diabetes,"Nasopharyngitis, potential for pancreatitis and severe joint pain",N/A
H17,Sofosbuvir,"HCV NS5B polymerase inhibitor",Treatment of chronic hepatitis C (as part of a combination regimen),"Fatigue, headache",Backbone of many modern HCV regimens.
I17,Solifenacin,"Anticholinergic",Treatment of overactive bladder (OAB),"Dry mouth, constipation, blurred vision",N/A
J17,Somatropin,"Growth hormone",Treatment of growth hormone deficiency,"Peripheral edema, arthralgia, hyperglycemia",N/A
K17,Sonidegib,"Hedgehog pathway inhibitor",Treatment of locally advanced basal cell carcinoma,"Musculoskeletal pain, alopecia, dysgeusia",Teratogenic.
L17,Sorafenib,"Kinase inhibitor",Treatment of hepatocellular carcinoma, renal cell carcinoma, and thyroid cancer,"Hand-foot skin reaction, diarrhea, hypertension",N/A
M17,Sotalol,"Beta-blocker/Antiarrhythmic",Treatment of ventricular and atrial arrhythmias,"Bradycardia, fatigue, QT prolongation (requires monitoring)",Class III antiarrhythmic properties.
N17,Spironolactone,"Aldosterone antagonist/Potassium-sparing diuretic",Treatment of heart failure, hypertension, and edema; also used for acne and hirsutism,"Hyperkalemia, gynecomastia",N/A
O17,Stavudine (d4T),"Nucleoside reverse transcriptase inhibitor (NRTI)",Treatment of HIV infection (largely obsolete),"Peripheral neuropathy, pancreatitis, lipoatrophy",High rate of toxicities.
P17,Streptokinase,Thrombolytic,Treatment of ST-elevation myocardial infarction, pulmonary embolism, DVT,"Bleeding, hypotension, allergic reactions",Antigenic; can only be used once.
Q17,Streptomycin,"Aminoglycoside antibiotic",Treatment of tuberculosis and other serious infections,"Nephrotoxicity, ototoxicity",N/A
R17,Succinylcholine,"Depolarizing neuromuscular blocker",Skeletal muscle relaxation for intubation or surgery,"Malignant hyperthermia, hyperkalemia, muscle fasciculations",Rapid onset and short duration.
S17,Sucralfate,"Mucosal protectant",Treatment of ulcers,"Constipation",Can bind to and inhibit absorption of other drugs.
T17,Sufentanil,"Opioid analgesic",Analgesia and anesthesia,"Respiratory depression, bradycardia, muscle rigidity",Extremely potent; about 5-10 times more potent than fentanyl.
U17,Sugammadex,"Selective relaxant binding agent",Reversal of neuromuscular blockade induced by rocuronium or vecuronium,"Anaphylaxis, bradycardia",N/A
V17,Sulconazole,Antifungal,Topical treatment of tinea infections,N/A,N/A
W17,Sulfacetamide,Sulfonamide antibiotic,Topical/ophthalmic treatment of bacterial infections,"Local irritation, hypersensitivity reactions",N/A
X17,Sulfamethoxazole/Trimethoprim (SMX/TMP),Antibiotic combination,Treatment of various bacterial infections, especially UTIs, PJP, and MRSA,"Rash (including Stevens-Johnson syndrome), hyperkalemia, myelosuppression",Allergy to sulfa drugs.
Y17,Sulfasalazine,"Aminosalicylate/DMARD",Treatment of ulcerative colitis and rheumatoid arthritis,"Nausea, headache, rash",Can cause yellow-orange discoloration of skin and urine.
Z17,Sulindac,NSAID,Relief of pain and inflammation,GI upset, increased risk of cardiovascular events,Prodrug.
AA4,Sumatriptan,5-HT1 receptor agonist (triptan),Acute treatment of migraine and cluster headaches,Chest tightness/pressure, dizziness, tingling sensations,Contraindicated in ischemic heart disease.
BB4,Sunitinib,Kinase inhibitor,Treatment of renal cell carcinoma, GIST, and pancreatic neuroendocrine tumors,Hepatotoxicity (boxed warning), fatigue, diarrhea, skin discoloration,N/A
CC4,Suvorexant,Orexin receptor antagonist,Treatment of insomnia,Next-day somnolence,N/A
DD4,Tacrolimus,Calcineurin inhibitor,Prevention of organ transplant rejection; topical use for atopic dermatitis,Nephrotoxicity, hypertension, neurotoxicity, increased risk of infections and malignancy (boxed warnings),Requires therapeutic drug monitoring.
EE4,Tadalafil,PDE-5 inhibitor,Treatment of erectile dysfunction, BPH, and pulmonary arterial hypertension,Headache, flushing, back pain,Contraindicated with nitrates.
FF4,Tafamidis,Transthyretin stabilizer,Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis,Urinary tract infection, diarrhea,N/A
GG4,Tamoxifen,Selective estrogen receptor modulator (SERM),Treatment and prevention of breast cancer,Hot flashes, increased risk of uterine cancer and venous thromboembolism,N/A
HH4,Tamsulosin,Alpha-1A blocker,Treatment of benign prostatic hyperplasia (BPH),Dizziness, retrograde ejaculation,More selective for alpha-1A receptors in the prostate, less likely to cause hypotension.
II4,Tapentadol,Opioid agonist/Norepinephrine reuptake inhibitor,Relief of moderate to severe pain,Nausea, dizziness, somnolence, seizure risk,Controlled substance.
JJ4,Tazarotene,Retinoid,Topical treatment of psoriasis, acne, and photoaging,Skin irritation, photosensitivity,Teratogenic.
KK4,Tedizolid,Oxazolidinone antibiotic,Treatment of acute bacterial skin and skin structure infections (ABSSSI),Nausea, headache, diarrhea,Similar to linezolid but may have less risk of myelosuppression.
LL4,Tegaserod,5-HT4 receptor partial agonist,Treatment of IBS-C in women under 65,Increased risk of heart attack, stroke, and unstable angina (boxed warning),Use is restricted.
MM4,Telavancin,Lipoglycopeptide antibiotic,Treatment of complicated skin infections and hospital-acquired pneumonia,"Increased mortality in patients with pre-existing renal impairment (boxed warning), nephrotoxicity, QT prolongation",N/A
NN4,Telbivudine,Nucleoside analog,Treatment of chronic hepatitis B,"Fatigue, headache, myopathy",Risk of lactic acidosis.
OO4,Telmisartan,Angiotensin II receptor blocker (ARB),Treatment of hypertension,Dizziness, hyperkalemia,Avoid in pregnancy.
PP4,Temazepam,Benzodiazepine,Short-term treatment of insomnia,Drowsiness, dizziness, dependence,N/A
QQ4,Temsirolimus,mTOR inhibitor,Treatment of advanced renal cell carcinoma,Myelosuppression, rash, hyperglycemia,Administered IV.
RR4,Tenofovir alafenamide (TAF),Nucleoside reverse transcriptase inhibitor (NRTI),Treatment of HIV and chronic hepatitis B,Generally well-tolerated, lower risk of renal and bone toxicity than TDF,Prodrug that delivers tenofovir more efficiently to target cells.
SS4,Tenofovir disoproxil fumarate (TDF),Nucleoside reverse transcriptase inhibitor (NRTI),Treatment of HIV and chronic hepatitis B,"Nephrotoxicity, bone mineral density loss",N/A
TT4,Terazosin,Alpha-1 blocker,Treatment of hypertension and BPH,First-dose syncope, dizziness,N/A
UU4,Terbinafine,Antifungal,Treatment of fungal infections of the nail (oral) and skin (topical),"Hepatotoxicity (oral use), headache, rash",Requires monitoring of liver function for oral use.
VV4,Terbutaline,Beta-2 adrenergic agonist,Treatment of asthma (bronchospasm); tocolytic to delay preterm labor (off-label),"Tachycardia, tremor, nervousness","Use as a tocolytic has a boxed warning against prolonged use (> 48-72 hours) due to risk of serious maternal heart problems and death."
WW4,Terconazole,Azole antifungal,Topical treatment of vulvovaginal candidiasis,Local irritation, headache,N/A
XX4,Testosterone,Androgen,Testosterone replacement therapy,Increased risk of cardiovascular events, prostate cancer; virilization in women and children upon contact,Controlled substance.
YY4,Tetrabenazine,Vesicular monoamine transporter 2 (VMAT2) inhibitor,Treatment of chorea associated with Huntington's disease,"Depression and suicidality (boxed warning), parkinsonism, somnolence",N/A
ZZ4,Tetracycline,Tetracycline antibiotic,Treatment of various bacterial infections, acne,GI upset, photosensitivity, tooth discoloration in children,Do not take with dairy or antacids.
A18,Thalidomide,Immunomodulatory agent,Treatment of multiple myeloma and erythema nodosum leprosum,"Severe life-threatening birth defects (boxed warning), thromboembolism, peripheral neuropathy",Requires enrollment in a restricted distribution program (REMS).
B18,Theophylline,Methylxanthine,Treatment of asthma and COPD,Tachycardia, nausea, seizures,Narrow therapeutic index; requires blood level monitoring.
C18,Thiabendazole,Anthelmintic,Treatment of various parasitic worm infections (largely replaced),Nausea, vomiting, dizziness,N/A
D18,Thioguanine,Purine antimetabolite,Treatment of acute myeloid leukemia (AML),Myelosuppression, hepatotoxicity,N/A
E18,Thioridazine,Typical antipsychotic,Treatment of schizophrenia (rarely used),QT prolongation (boxed warning), sedation, anticholinergic effects,Use is limited due to cardiotoxicity.
F18,Thiotepa,Alkylating agent,Treatment of various cancers,Myelosuppression,N/A
G18,Thiothixene,Typical antipsychotic,Treatment of schizophrenia,Extrapyramidal symptoms, sedation,N/A
H18,Tiagabine,Anticonvulsant,Adjunctive treatment of partial-onset seizures,"Can cause seizures in patients without epilepsy (boxed warning), dizziness, somnolence",N/A
I18,Ticagrelor,Antiplatelet agent,Reduces thrombotic events in patients with acute coronary syndrome,"Bleeding, dyspnea",Can cause bradyarrhythmias.
J18,Tigecycline,Glycylcycline antibiotic,Treatment of complicated skin, intra-abdominal, and community-acquired pneumonia infections,"Increased all-cause mortality (boxed warning), severe nausea and vomiting",Use only when alternative treatments are not suitable.
K18,Tildrakizumab,IL-23 inhibitor,Treatment of moderate-to-severe plaque psoriasis,Upper respiratory infections,N/A
L18,Timolol,Beta-blocker (non-selective),Ophthalmic use for glaucoma; oral use for hypertension and post-MI,Systemic side effects (bradycardia, bronchospasm) can occur even with ophthalmic use,N/A
M18,Tinidazole,Nitroimidazole antibiotic/antiprotozoal,Treatment of protozoal and anaerobic bacterial infections,Metallic taste, nausea, disulfiram-like reaction with alcohol,Similar to metronidazole, but with a longer half-life.
N18,Tiotropium,Long-acting muscarinic antagonist (LAMA),Maintenance treatment of COPD and asthma,Dry mouth,Inhaled once daily.
O18,Tipranavir,Protease inhibitor,Treatment of HIV infection (with ritonavir),Hepatotoxicity (boxed warning), intracranial hemorrhage (boxed warning), rash,Must be boosted with ritonavir.
P18,Tirofiban,Glycoprotein IIb/IIIa inhibitor,Used in acute coronary syndrome,Bleeding, thrombocytopenia,Administered IV.
Q18,Tizanidine,Alpha-2 adrenergic agonist,Management of spasticity,Hypotension, drowsiness, dry mouth, hepatotoxicity,N/A
R18,Tobramycin,Aminoglycoside antibiotic,Treatment of serious bacterial infections; inhaled formulation for cystic fibrosis,Nephrotoxicity, ototoxicity,Can be administered IV or by inhalation.
S18,Tocilizumab,IL-6 receptor antagonist,Treatment of rheumatoid arthritis and other inflammatory conditions,Increased risk of serious infections (boxed warning), infusion reactions,N/A
T18,Tofacitinib,JAK inhibitor,Treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis,"Serious infections, malignancy, and thrombosis (boxed warnings)",N/A
U18,Tolbutamide,Sulfonylurea,Treatment of type 2 diabetes (rarely used),Hypoglycemia,Has been associated with increased cardiovascular mortality.
V18,Tolcapone,COMT inhibitor,Adjunctive therapy for Parkinson's disease,Hepatotoxicity (boxed warning), dyskinesias, hallucinations,Requires liver enzyme monitoring.
W18,Tolmetin,NSAID,Relief of pain and inflammation,GI upset, increased risk of cardiovascular events,N/A
X18,Tolterodine,Anticholinergic,Treatment of overactive bladder (OAB),Dry mouth, constipation,N/A
Y18,Tolvaptan,Vasopressin V2 receptor antagonist,Treatment of hyponatremia,"Too rapid correction of hyponatremia can cause osmotic demyelination (boxed warning), thirst, dry mouth",Requires inpatient initiation and monitoring.
Z18,Topiramate,Anticonvulsant,Treatment of seizures and migraine prophylaxis,Cognitive impairment ("brain fog"), paresthesias, weight loss,Can cause metabolic acidosis.
AA5,Topotecan,Topoisomerase I inhibitor,Treatment of ovarian cancer, small cell lung cancer, and cervical cancer,Myelosuppression, diarrhea,N/A
BB5,Toremifene,Selective estrogen receptor modulator (SERM),Treatment of metastatic breast cancer in postmenopausal women,Hot flashes, QT prolongation,N/A
CC5,Torsemide,Loop diuretic,Treatment of edema and hypertension,Hypokalemia, dehydration,Similar to furosemide.
DD5,Trabectedin,Alkylating agent,Treatment of liposarcoma and leiomyosarcoma,Neutropenia, nausea, hepatotoxicity,N/A
EE5,Tramadol,Atypical opioid agonist,Relief of moderate pain,Dizziness, nausea, constipation, seizure risk,Also has SNRI activity. Controlled substance.
FF5,Trandolapril,ACE inhibitor,Treatment of hypertension and heart failure post-MI,Cough, dizziness,N/A
GG5,Tranexamic acid,Antifibrinolytic,Treatment of heavy menstrual bleeding; prevention of bleeding in surgery,Thrombotic events, visual disturbances,N/A
HH5,Tranylcypromine,MAO inhibitor (non-selective),Treatment of depression,Orthostatic hypotension, dizziness, hypertensive crisis with tyramine-rich foods,Many food and drug interactions.
II5,Trastuzumab,Anti-HER2 monoclonal antibody,Treatment of HER2-positive breast cancer and gastric cancer,Cardiotoxicity, infusion reactions, pulmonary toxicity (boxed warnings),N/A
JJ5,Travoprost,Prostaglandin analog,Ophthalmic treatment of glaucoma,Iris color change (darkening), eyelash growth, ocular redness,N/A
KK5,Trazodone,Atypical antidepressant,Treatment of depression; commonly used off-label for insomnia,Sedation, priapism (rare), orthostatic hypotension,N/A
LL5,Treprostinil,Prostacyclin analog,Treatment of pulmonary arterial hypertension (PAH),Infusion site pain (subcutaneous), headache, jaw pain,Available in IV, SC, inhaled, and oral formulations.
MM5,Tretinoin,Retinoid,Topical treatment for acne; oral treatment for acute promyelocytic leukemia (APL),Skin irritation (topical); retinoic acid syndrome, headache (oral),Teratogenic.
NN5,Triamcinolone,Corticosteroid,Topical, injectable, inhaled, and oral use for various inflammatory conditions,Local or systemic side effects depending on formulation,N/A
OO5,Triamterene,Potassium-sparing diuretic,Treatment of edema (usually with another diuretic),Hyperkalemia, kidney stones,Can cause bluish discoloration of the urine.
PP5,Triazolam,Benzodiazepine,Short-term treatment of insomnia,Anterograde amnesia, drowsiness, dizziness,Short-acting.
QQ5,Trifluoperazine,Typical antipsychotic,Treatment of schizophrenia and anxiety,Extrapyramidal symptoms, sedation,N/A
RR5,Trifluridine/Tipiracil,Nucleoside analog combination,Treatment of metastatic colorectal cancer,Myelosuppression, fatigue, nausea,N/A
SS5,Trihexyphenidyl,Anticholinergic,Treatment of Parkinson's disease and drug-induced extrapyramidal symptoms,Dry mouth, blurred vision, constipation, confusion,Used to treat side effects of antipsychotics.
TT5,Trimethobenzamide,Antiemetic,Treatment of postoperative nausea and vomiting,Drowsiness, extrapyramidal symptoms,N/A
UU5,Trimipramine,Tricyclic antidepressant,Treatment of depression,Sedation, dry mouth, constipation,N/A
VV5,Triptorelin,GnRH agonist,Palliative treatment of advanced prostate cancer,Hot flashes, decreased libido,N/A
WW5,Trospium,Anticholinergic,Treatment of overactive bladder (OAB),Dry mouth, constipation,Less likely to cross the blood-brain barrier than oxybutynin.
XX5,Ulipristal,Selective progesterone receptor modulator,Emergency contraception,Headache, nausea, abdominal pain,N/A
YY5,Umeclidinium,Long-acting muscarinic antagonist (LAMA),Maintenance treatment of COPD,Nasopharyngitis, upper respiratory tract infection,Inhaled once daily.
ZZ5,Ustekinumab,IL-12 and IL-23 antagonist,Treatment of psoriasis, Crohn's disease, and ulcerative colitis,Nasopharyngitis, headache, fatigue,N/A
A19,Valacyclovir,Antiviral,Treatment of herpes virus infections (cold sores, genital herpes, shingles),Headache, nausea,Prodrug of acyclovir with better bioavailability.
B19,Valganciclovir,Antiviral,Treatment and prevention of CMV infection,Myelosuppression, headache, nausea,Prodrug of ganciclovir with better bioavailability.
C19,Valproic Acid,Anticonvulsant,Treatment of seizures, bipolar disorder, and migraine prevention,Hepatotoxicity, pancreatitis, teratogenicity (neural tube defects) (boxed warnings),N/A
D19,Valsartan,Angiotensin II receptor blocker (ARB),Treatment of hypertension and heart failure,Dizziness, hyperkalemia,Avoid in pregnancy.
E19,Vancomycin,Glycopeptide antibiotic,Treatment of serious gram-positive infections, including MRSA,Nephrotoxicity, infusion reaction ("red man syndrome"),Requires therapeutic drug monitoring.
F19,Vardenafil,PDE-5 inhibitor,Treatment of erectile dysfunction,Headache, flushing, nasal congestion,Contraindicated with nitrates.
G19,Varenicline,Nicotinic receptor partial agonist,Smoking cessation aid,Nausea, abnormal dreams, risk of serious neuropsychiatric events,N/A
H19,Vedolizumab,Integrin receptor antagonist,Treatment of ulcerative colitis and Crohn's disease,Nasopharyngitis, headache, arthralgia,Gut-selective; less risk of systemic infections than other biologics.
I19,Vemurafenib,Kinase inhibitor (BRAF inhibitor),Treatment of BRAF V600E mutation-positive melanoma,Rash, photosensitivity, arthralgia, risk of new skin cancers,N/A
J19,Venlafaxine,SNRI antidepressant,Treatment of depression, anxiety, and panic disorder,Nausea, headache, insomnia, can increase blood pressure,Can cause significant withdrawal symptoms.
K19,Verapamil,Calcium channel blocker,Treatment of hypertension, angina, and arrhythmias,Constipation, gingival hyperplasia, bradycardia,N/A
L19,Verteporfin,Photosensitizer,Used in photodynamic therapy for macular degeneration,Infusion site reactions, visual disturbances, photosensitivity,Avoid exposure to bright light for 5 days after treatment.
M19,Vigabatrin,Anticonvulsant,Treatment of infantile spasms and refractory complex partial seizures,Permanent vision loss (boxed warning), somnolence, fatigue,Requires enrollment in a restricted distribution program.
N19,Vilazodone,SSRI and 5-HT1A partial agonist,Treatment of depression,Diarrhea, nausea, dizziness,Take with food.
O19,Vildagliptin,DPP-4 inhibitor,Treatment of type 2 diabetes (not available in the US),Nasopharyngitis, headache,N/A
P19,Vilanterol,Long-acting beta-2 agonist (LABA),Used in combination with other drugs (e.g., fluticasone) for asthma and COPD,Increased risk of asthma-related death when used as monotherapy (boxed warning),N/A
Q19,Vinblastine,Vinca alkaloid,Treatment of various cancers,Myelosuppression, peripheral neuropathy,Fatal if given intrathecally (boxed warning).
R19,Vincristine,Vinca alkaloid,Treatment of various cancers,Peripheral neuropathy (major toxicity), constipation,Fatal if given intratheally (boxed warning).
S19,Vinorelbine,Vinca alkaloid,Treatment of non-small cell lung cancer,Myelosuppression, peripheral neuropathy,Fatal if given intrathecally (boxed warning).
T19,Vismodegib,Hedgehog pathway inhibitor,Treatment of metastatic or locally advanced basal cell carcinoma,Muscle spasms, alopecia, dysgeusia,Teratogenic.
U19,Vorapaxar,PAR-1 antagonist,Reduces thrombotic events in patients with a history of MI or PAD,Bleeding (boxed warning),Contraindicated in patients with history of stroke, TIA, or intracranial hemorrhage.
V19,Voriconazole,Azole antifungal,Treatment of invasive aspergillosis and other serious fungal infections,Visual disturbances, hepatotoxicity, photosensitivity,Potent inhibitor of many CYP enzymes; non-linear kinetics.
W19,Vortioxetine,Atypical antidepressant,Treatment of depression,Nausea,N/A
X19,Warfarin,Vitamin K antagonist,Anticoagulant for prevention and treatment of blood clots,Bleeding (boxed warning),Many drug and food (Vitamin K) interactions; requires INR monitoring.
Y19,Zafirlukast,Leukotriene receptor antagonist,Treatment of asthma,Hepatotoxicity, headache,N/A
Z19,Zaleplon,Nonbenzodiazepine hypnotic,Short-term treatment of insomnia,Drowsiness, dizziness,Ultra-short half-life.
AA6,Zidovudine (AZT),Nucleoside reverse transcriptase inhibitor (NRTI),Treatment of HIV infection,Myelosuppression (anemia, neutropenia), nausea, headache,The first drug approved for HIV.
BB6,Ziprasidone,Atypical antipsychotic,Treatment of schizophrenia and bipolar disorder,QT prolongation (contraindicated in patients with QT prolongation), somnolence, rash,Should be taken with food.
CC6,Zoledronic acid,Bisphosphonate,Treatment of osteoporosis, hypercalcemia of malignancy, and bone metastases,Fever, flu-like symptoms (acute phase reaction); osteonecrosis of the jaw, nephrotoxicity,Administered IV.
DD6,Zolmitriptan,5-HT1 receptor agonist (triptan),Acute treatment of migraine,Dizziness, paresthesias, chest tightness,Available as nasal spray and oral tablet.
EE6,Zolpidem,Nonbenzodiazepine hypnotic,Short-term treatment of insomnia,Drowsiness, dizziness, complex sleep-related behaviors,Controlled substance.
FF6,Zonisamide,Anticonvulsant,Adjunctive treatment of partial-onset seizures,Somnolence, dizziness, cognitive impairment,Sulfonamide derivative; risk of rash.
GG6,Azelastine,Antihistamine,"Relief of nasal allergy symptoms (nasal spray) and allergic conjunctivitis (eye drops)",Bitter taste, somnolence, headache,N/A
HH6,Emedastine,Antihistamine,"Relief of allergic conjunctivitis (eye drops)",Headache, abnormal dreams,N/A
II6,Levocabastine,Antihistamine,"Relief of allergic conjunctivitis (eye drops)",Transient stinging, headache,N/A
JJ6,Olopatadine,Antihistamine/Mast cell stabilizer,"Relief of allergic conjunctivitis (eye drops) and nasal allergy symptoms (nasal spray)",Headache, altered taste,N/A
KK6,Tenapanor,NHE3 Inhibitor,Treatment of Irritable Bowel Syndrome with Constipation (IBS-C),Diarrhea, Abdominal Distension,"Risk of Serious Dehydration in Pediatric Patients"
LL6,Tepotinib,MET inhibitor,"Treatment of metastatic non-small cell lung cancer (NSCLC) with METex14 skipping alterations",Edema, fatigue, nausea,"Interstitial Lung Disease (Pneumonitis), Hepatotoxicity"
MM6,Tovorafenib,Type II RAF inhibitor,Treatment of pediatric low-grade glioma (LGG) with a BRAF alteration,Hair color changes, fatigue, rash,"Skin Toxicity, Hemorrhage, Embryo-Fetal Toxicity"
NN6,Capivasertib,AKT inhibitor,"Treatment of HR-positive, HER2-negative breast cancer with specific gene alterations",Diarrhea, skin adverse reactions, hyperglycemia,"Hyperglycemia, Diarrhea, Cutaneous Adverse Reactions"
OO6,Fruquintinib,VEGFR inhibitor,"Treatment of metastatic colorectal cancer",Hypertension, hand-foot skin reaction, proteinuria,"Hypertension, Hemorrhagic Events, Impaired Wound Healing"
PP6,Repotrectinib,ROS1/TRK inhibitor,"Treatment of ROS1-positive non-small cell lung cancer (NSCLC) and NTRK gene fusion-positive solid tumors",Dizziness, dysgeusia, peripheral neuropathy,"Central Nervous System Effects, Interstitial Lung Disease/Pneumonitis, Hepatotoxicity"
QQ6,Toripalimab,PD-1 blocking antibody,"Treatment of nasopharyngeal carcinoma",Fatigue, hypothyroidism, musculoskeletal pain,"Immune-Mediated Adverse Reactions, Infusion-Related Reactions"
RR6,Ivosidenib,IDH1 inhibitor,"Treatment of acute myeloid leukemia (AML) and cholangiocarcinoma with a susceptible IDH1 mutation",Fatigue, nausea, diarrhea,"Differentiation Syndrome, QT Prolongation, Guillain-Barr Syndrome"
SS6,Olaparib,PARP inhibitor,Treatment of ovarian, breast, pancreatic, and prostate cancer with specific mutations,Anemia, fatigue, nausea,"Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML), Pneumonitis"
TT6,Talazoparib,PARP inhibitor,Treatment of gBRCAm HER2-negative locally advanced or metastatic breast cancer,Anemia, fatigue, nausea,"Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML), Myelosuppression"
UU6,Niraparib,PARP inhibitor,Maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancer,Thrombocytopenia, anemia, nausea,"Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML), Myelosuppression"
VV6,Rucaparib,PARP inhibitor,Treatment of ovarian and prostate cancer with specific mutations,Nausea, anemia, fatigue,"Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML)"
WW6,Abemaciclib,CDK4/6 inhibitor,Treatment of HR-positive, HER2-negative breast cancer,Diarrhea, neutropenia, fatigue,"Diarrhea, Interstitial Lung Disease (ILD)/Pneumonitis, Hepatotoxicity"
XX6,Ribociclib,CDK4/6 inhibitor,Treatment of HR-positive, HER2-negative breast cancer,Neutropenia, nausea, fatigue,"QT Prolongation, Interstitial Lung Disease/Pneumonitis, Hepatotoxicity"
YY6,Palbociclib,CDK4/6 inhibitor,Treatment of HR-positive, HER2-negative breast cancer,Neutropenia, fatigue, nausea,"Interstitial Lung Disease (ILD)/Pneumonitis"
ZZ6,Enfortumab vedotin,Nectin-4-directed antibody-drug conjugate,Treatment of locally advanced or metastatic urothelial cancer,Rash, peripheral neuropathy, fatigue,"Skin Reactions, Hyperglycemia, Pneumonitis/Interstitial Lung Disease"
A10,Sacituzumab govitecan,Trop-2-directed antibody-drug conjugate,Treatment of metastatic triple-negative breast cancer and urothelial cancer,Neutropenia, diarrhea, nausea,"Severe Neutropenia, Severe Diarrhea"
B10,Trastuzumab deruxtecan,HER2-directed antibody-drug conjugate,Treatment of HER2-positive or HER2-low breast cancer, non-small cell lung cancer, and gastric cancer,Nausea, fatigue, neutropenia,"Interstitial Lung Disease/Pneumonitis, Neutropenia"
C10,Polatuzumab vedotin,CD79b-directed antibody-drug conjugate,Treatment of diffuse large B-cell lymphoma,Peripheral neuropathy, neutropenia, fatigue,"Peripheral Neuropathy, Infusion-Related Reactions, Myelosuppression"
D10,Belantamab mafodotin,BCMA-directed antibody-drug conjugate,Treatment of multiple myeloma,Ocular toxicity (changes in vision, dry eyes), thrombocytopenia,"Ocular Toxicity"
E10,Loncastuximab tesirine,CD19-directed antibody-drug conjugate,Treatment of large B-cell lymphoma,Thrombocytopenia, elevated GGT, fatigue,"Effusion and Edema, Myelosuppression"
F10,Tisotumab vedotin,Tissue factor-directed antibody-drug conjugate,Treatment of recurrent or metastatic cervical cancer,Ocular adverse reactions, peripheral neuropathy, hemorrhage,"Ocular Adverse Reactions"
G10,Mirvetuximab soravtansine,Folate receptor alpha-directed antibody-drug conjugate,Treatment of platinum-resistant ovarian cancer,Ocular toxicity, fatigue, nausea,"Ocular Adverse Reactions"
H10,Margetuximab,HER2-directed antibody,Treatment of HER2-positive metastatic breast cancer,Infusion-related reactions, fatigue, nausea,"Left Ventricular Dysfunction, Embryo-Fetal Toxicity"
I10,Tafasitamab,CD19-directed antibody,Treatment of diffuse large B-cell lymphoma (in combination with lenalidomide),Infusion-related reactions, neutropenia, fatigue,"Infusion-Related Reactions, Myelosuppression"
J10,Amivantamab,EGFR and MET bispecific antibody,Treatment of NSCLC with EGFR exon 20 insertion mutations,Infusion-related reaction, rash, paronychia,"Infusion Related Reactions, Interstitial Lung Disease/Pneumonitis, Skin and Ocular Toxicity"
K10,Teclistamab,BCMA and CD3 bispecific antibody,Treatment of multiple myeloma,Cytokine release syndrome, neurologic toxicity, neutropenia,"Cytokine Release Syndrome, Neurologic Toxicity including ICANS"
L10,Mosunetuzumab,CD20 and CD3 bispecific antibody,Treatment of follicular lymphoma,Cytokine release syndrome, fatigue, rash,"Cytokine Release Syndrome"
M10,Glofitamab,CD20 and CD3 bispecific antibody,Treatment of diffuse large B-cell lymphoma,Cytokine release syndrome, infusion-related reaction, neutropenia,"Cytokine Release Syndrome"
N10,Epcoritamab,CD20 and CD3 bispecific antibody,Treatment of diffuse large B-cell lymphoma,Cytokine release syndrome, injection site reaction, fatigue,"Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)"
O10,Talquetamab,GPRC5D and CD3 bispecific antibody,Treatment of multiple myeloma,Oral toxicity (dysgeusia, dysphagia), skin toxicity, cytokine release syndrome,"Oral and Skin Toxicity, Cytokine Release Syndrome"
P10,Elranatamab,BCMA and CD3 bispecific antibody,Treatment of multiple myeloma,Cytokine release syndrome, injection site reaction, anemia,"Cytokine Release Syndrome, Neurologic Toxicity including ICANS"
Q10,Odronextamab,CD20 and CD3 bispecific antibody,Treatment of follicular lymphoma and diffuse large B-cell lymphoma,Cytokine release syndrome, neutropenia, infusion-related reaction,"Cytokine Release Syndrome, Neurologic Toxicity including ICANS"
R10,Lonafarnib,Farnesyltransferase inhibitor,Treatment of Hutchinson-Gilford progeria syndrome and progeroid laminopathies,Nausea, vomiting, diarrhea,"Reduced visual acuity, renal toxicity"
S10,Selumetinib,MEK inhibitor,Treatment of neurofibromatosis type 1 (NF1) with symptomatic, inoperable plexiform neurofibromas,Cardiomyopathy, ocular toxicity, skin rash,"Cardiomyopathy, Ocular Toxicity, Serous Retinopathy"
T10,Avapritinib,Kinase inhibitor,Treatment of gastrointestinal stromal tumors (GIST) with a PDGFRA exon 18 mutation and advanced systemic mastocytosis,Edema, nausea, cognitive impairment,"Intracranial Hemorrhage"
U10,Ripretinib,Kinase inhibitor,Treatment of advanced gastrointestinal stromal tumor (GIST),Alopecia, fatigue, nausea,"New Primary Cutaneous Malignancies, Hypertension, Cardiac Dysfunction"
V10,Tucatinib,HER2 kinase inhibitor,Treatment of HER2-positive breast cancer,Diarrhea, hepatotoxicity, fatigue,"Diarrhea, Hepatotoxicity"
W10,Pemigatinib,FGFR inhibitor,Treatment of cholangiocarcinoma with an FGFR2 fusion or other rearrangement,Hyperphosphatemia, ocular toxicity, alopecia,"Ocular Toxicity, Hyperphosphatemia"
X10,Infigratinib,FGFR inhibitor,Treatment of cholangiocarcinoma with an FGFR2 fusion or other rearrangement,Hyperphosphatemia, ocular toxicity, stomatitis,"Ocular Toxicity (Retinal Pigment Epithelial Detachment), Hyperphosphatemia"
Y10,Erdafitinib,FGFR inhibitor,Treatment of urothelial carcinoma with susceptible FGFR3 or FGFR2 genetic alterations,Hyperphosphatemia, ocular toxicity, stomatitis,"Ocular Disorders, Hyperphosphatemia"
Z10,Asciminib,Kinase inhibitor (STAMP inhibitor),Treatment of chronic myeloid leukemia (CML),Thrombocytopenia, neutropenia, musculoskeletal pain,"Pancreatitis, QT Prolongation, Hypertension"
AA7,Sotorasib,KRAS G12C inhibitor,Treatment of KRAS G12C-mutated non-small cell lung cancer (NSCLC),Hepatotoxicity, diarrhea, nausea,"Hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis"
BB7,Adagrasib,KRAS G12C inhibitor,Treatment of KRAS G12C-mutated non-small cell lung cancer (NSCLC),Nausea, diarrhea, QT prolongation,"QTc Interval Prolongation, Hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis"
CC7,Tepotinib,MET inhibitor,Treatment of metastatic non-small cell lung cancer (NSCLC) with METex14 skipping alterations,Edema, fatigue, nausea,"Interstitial Lung Disease (Pneumonitis), Hepatotoxicity"
DD7,Capmatinib,MET inhibitor,Treatment of metastatic non-small cell lung cancer (NSCLC) with METex14 skipping alterations,Peripheral edema, nausea, fatigue,"Interstitial Lung Disease (Pneumonitis), Hepatotoxicity"
EE7,Tepotinib,MET inhibitor,"Treatment of metastatic non-small cell lung cancer (NSCLC) with METex14 skipping alterations",Edema, fatigue, nausea,"Interstitial Lung Disease (Pneumonitis), Hepatotoxicity"
FF7,Pralsetinib,RET inhibitor,Treatment of RET fusion-positive non-small cell lung cancer (NSCLC) and thyroid cancer,Hypertension, neutropenia, hepatotoxicity,"Interstitial Lung Disease (ILD)/Pneumonitis, Hypertension, Hepatotoxicity"
GG7,Selpercatinib,RET inhibitor,Treatment of RET fusion-positive non-small cell lung cancer (NSCLC) and thyroid cancer,Hypertension, elevated liver enzymes, dry mouth,"Hepatotoxicity, Hypertension, QT Prolongation"
HH7,Larotrectinib,TRK inhibitor,Treatment of solid tumors with an NTRK gene fusion,Elevated liver enzymes, fatigue, dizziness,"Neurotoxicity, Hepatotoxicity"
II7,Entrectinib,TRK/ROS1/ALK inhibitor,Treatment of solid tumors with an NTRK gene fusion and ROS1-positive NSCLC,Congestive heart failure, CNS effects, skeletal fractures,"Congestive Heart Failure, CNS Effects, Skeletal Fractures"
JJ7,Zanubrutinib,BTK inhibitor,Treatment of mantle cell lymphoma, Waldenstrm macroglobulinemia, and marginal zone lymphoma,Neutropenia, upper respiratory tract infection, bruising,"Hemorrhage, Infections, Cardiac Arrhythmias"
KK7,Orelabrutinib,BTK inhibitor,Treatment of mantle cell lymphoma and chronic lymphocytic leukemia (Not FDA approved),Infection, neutropenia, rash,N/A
LL7,Tirabrutinib,BTK inhibitor,Treatment of Waldenstrms macroglobulinemia and lymphoplasmacytic lymphoma (Not FDA approved),Hemorrhage, rash,N/A
MM7,Fedratinib,JAK2 inhibitor,Treatment of myelofibrosis,Encephalopathy (including Wernicke's) (boxed warning), anemia, GI toxicity,"Serious and Fatal Encephalopathy"
NN7,Pacritinib,JAK2/IRAK1 inhibitor,Treatment of myelofibrosis with severe thrombocytopenia,Hemorrhage, diarrhea, thrombocytopenia,"Serious Hemorrhage, Thrombosis, Infections"
OO7,Momelotinib,JAK1/JAK2/ACVR1 inhibitor,Treatment of myelofibrosis with anemia,Anemia, thrombocytopenia, symptomatic improvement,"Hepatotoxicity, Major Adverse Cardiac Events, Thrombosis"
PP7,Baricitinib,JAK inhibitor,Treatment of rheumatoid arthritis, alopecia areata, and COVID-19,"Serious infections, malignancy, thrombosis (boxed warnings)",N/A
QQ7,Upadacitinib,JAK inhibitor,Treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and ulcerative colitis,"Serious infections, malignancy, thrombosis (boxed warnings)",N/A
RR7,Filgotinib,JAK inhibitor,Treatment of rheumatoid arthritis,"Serious infections, malignancy, thrombosis (boxed warnings)",Testicular toxicity concern.
SS7,Abrocitinib,JAK1 inhibitor,Treatment of atopic dermatitis,"Serious infections, malignancy, thrombosis (boxed warnings), nausea",N/A
TT7,Deucravacitinib,TYK2 inhibitor,Treatment of moderate-to-severe plaque psoriasis,"Infections, nasopharyngitis",Different safety profile from other JAK inhibitors.
UU7,Ritlecitinib,JAK3/TEC family kinase inhibitor,Treatment of severe alopecia areata,Infections, headache, dizziness,N/A
VV7,Voxelotor,Hemoglobin S polymerization inhibitor,Treatment of sickle cell disease,Headache, diarrhea, rash,N/A
WW7,Mitapivat,Pyruvate kinase activator,Treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency,Estrone increase, back pain, arthralgia,N/A
XX7,Igan,N/A,N/A,N/A,N/A
YY7,Pegcetacoplan,Complement C3 inhibitor,Treatment of paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy,"Serious meningococcal infections, injection site reactions",Vaccinate against Neisseria meningitidis.
ZZ7,Danicopan,Factor D inhibitor,Add-on therapy for paroxysmal nocturnal hemoglobinuria (PNH) with extravascular hemolysis,Headache, fatigue, elevated liver enzymes,"Increased susceptibility to encapsulated bacterial infections"
A111,Iptacopan,Factor B inhibitor,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Headache, nasopharyngitis, diarrhea,"Serious Infections Caused by Encapsulated Bacteria"
B111,Crovalimab,Complement C5 inhibitor,Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Upper respiratory tract infection, infusion-related reactions,"Serious Meningococcal Infections and Other Encapsulated Bacteria"
C111,Pozelimab,Complement C5 inhibitor,Treatment of CD55-deficient protein-losing enteropathy (CHAPLE disease),Upper respiratory tract infection, fracture, urticaria,"Serious Meningococcal Infections and other Encapsulated Bacterial Infections"
D111,Cemdisiran,Complement C5 siRNA,Treatment of paroxysmal nocturnal hemoglobinuria (PNH) (Not FDA approved),N/A,"Serious Meningococcal Infections and other Encapsulated Bacterial Infections"
E111,Fenebrutinib,BTK inhibitor,Investigational for multiple sclerosis and other autoimmune diseases,N/A,N/A
F111,Remibrutinib,BTK inhibitor,Investigational for chronic spontaneous urticaria,N/A,N/A
G111,Evobrutinib,BTK inhibitor,Investigational for multiple sclerosis,N/A,N/A
H111,Bexagliflozin,SGLT2 inhibitor,Treatment of type 2 diabetes,Genital mycotic infections, urinary tract infection,N/A
I111,Sotagliflozin,Dual SGLT1/SGLT2 inhibitor,Treatment of heart failure,Diarrhea, genital mycotic infections,"Diabetic Ketoacidosis, Fournier's Gangrene"
J111,Luspatercept,TGF- ligand trap,Treatment of anemia in beta thalassemia and myelodysplastic syndromes,Fatigue, headache, hypertension,"Thrombosis/Thromboembolism, Hypertension"
K111,Sutimlimab,Complement C1s inhibitor,Treatment of hemolysis in patients with cold agglutinin disease (CAD),Infusion-related reactions, hypertension, headache,"Serious Infections"
L111,Anifrolumab,Type I interferon receptor antagonist,Treatment of systemic lupus erythematosus (SLE),Upper respiratory tract infection, herpes zoster, infusion reactions,"Serious Infections, Hypersensitivity Reactions"
M111,Tezepelumab,TSLP blocker,Add-on maintenance treatment for severe asthma,Arthralgia, pharyngitis, injection site reactions,N/A
N111,Mavacamten,Cardiac myosin inhibitor,Treatment of obstructive hypertrophic cardiomyopathy (HCM),Reduced ejection fraction, dizziness, syncope,"Heart Failure"
O111,Aficamten,Cardiac myosin inhibitor,Investigational for obstructive hypertrophilic cardiomyopathy (HCM),N/A,N/A
P111,Lenacapavir,HIV-1 capsid inhibitor,Treatment of multi-drug resistant HIV-1 infection,Injection site reactions, nausea,Administered subcutaneously every 6 months.
Q111,Inclisiran,siRNA,Lowers LDL cholesterol,Injection site reaction, arthralgia,N/A
R111,Bempedoic acid,ACL inhibitor,Lowers LDL cholesterol,Hyperuricemia, tendon rupture,N/A
S111,Obeticholic acid,Farnesoid X receptor (FXR) agonist,Treatment of primary biliary cholangitis (PBC),Severe pruritus, hepatic decompensation in cirrhotic patients (boxed warning),N/A
T111,Elafibranor,PPAR alpha/delta agonist,Investigational for primary biliary cholangitis (PBC),N/A,N/A
U111,Lanifibranor,Pan-PPAR agonist,Investigational for non-alcoholic steatohepatitis (NASH),N/A,N/A
V111,Resmetirom,Thyroid hormone receptor-beta agonist,Treatment of non-alcoholic steatohepatitis (NASH),Diarrhea, nausea,"Hepatotoxicity"
W111,Semaglutide,GLP-1 receptor agonist,"Treatment of type 2 diabetes and obesity; reduces risk of major cardiovascular events",Nausea, vomiting, diarrhea,"Risk of Thyroid C-Cell Tumors"
X111,Tirzepatide,GIP and GLP-1 receptor agonist,"Treatment of type 2 diabetes and obesity",Nausea, vomiting, diarrhea,"Risk of Thyroid C-Cell Tumors"
Y111,Cagrilintide,Amylin analog,Investigational for weight management (often with semaglutide),N/A,N/A
Z111,Pegilodecakin,IL-10 receptor agonist,Investigational for cancer,N/A,N/A
A112,Bempegaldesleukin,IL-2 agonist,Investigational for cancer,N/A,N/A
B112,Donanemab,Amyloid beta-directed antibody,Investigational for Alzheimer's disease,Amyloid-related imaging abnormalities (ARIA), infusion-related reactions,N/A
C112,Lecanemab,Amyloid beta-directed antibody,Treatment of Alzheimer's disease,Amyloid-related imaging abnormalities (ARIA), infusion-related reactions,N/A
D112,Aducanumab,Amyloid beta-directed antibody,Treatment of Alzheimer's disease,Amyloid-related imaging abnormalities (ARIA), headache,N/A
E112,Gantenerumab,Amyloid beta-directed antibody,Investigational for Alzheimer's disease,N/A,N/A
F112,Birtamimab,Amyloid-directed antibody,Investigational for AL amyloidosis,N/A,N/A
G112,Atogepant,CGRP receptor antagonist,Preventive treatment of migraine,Nausea, constipation, fatigue,N/A
H112,Rimegepant,CGRP receptor antagonist,Acute and preventive treatment of migraine,Nausea, somnolence,N/A
I112,Ubrogepant,CGRP receptor antagonist,Acute treatment of migraine,Nausea, somnolence,N/A
J112,Zavegepant,CGRP receptor antagonist,Acute treatment of migraine (nasal spray),Unusual taste, nausea, nasal discomfort,N/A
K112,Lasmiditan,5-HT1F receptor agonist,Acute treatment of migraine,Dizziness, fatigue, paresthesia,CNS depression; should not drive for at least 8 hours.
L112,LetibotulinumtoxinA,Acetylcholine release inhibitor,Temporary improvement of glabellar lines,Headache, eyelid ptosis,N/A
M112,DaxibotulinumtoxinA,Acetylcholine release inhibitor,Temporary improvement of glabellar lines,Headache, eyelid ptosis,N/A
N112,Relatlimab,LAG-3-blocking antibody,Treatment of unresectable or metastatic melanoma (in combination with nivolumab),Fatigue, musculoskeletal pain, rash,"Immune-Mediated Adverse Reactions"
O112,Giredestrant,SERD,Investigational for ER-positive breast cancer,N/A,N/A
P112,Camizestrant,SERD,Investigational for ER-positive breast cancer,N/A,N/A
Q112,Imlunestrant,SERD,Investigational for ER-positive breast cancer,N/A,N/A
R112,Verinurad,URAT1 inhibitor,Investigational for gout,N/A,N/A
S112,Daprodustat,HIF-PH inhibitor,Treatment of anemia of chronic kidney disease,"Increased risk of thrombotic vascular events",N/A
T112,Roxadustat,HIF-PH inhibitor,Treatment of anemia of chronic kidney disease,"Increased risk of thrombotic vascular events",N/A
U112,Vadadustat,HIF-PH inhibitor,Treatment of anemia of chronic kidney disease,"Increased risk of thrombotic vascular events",N/A
V112,Bavdegalutamide,PROTAC,Investigational for prostate cancer,N/A,N/A
W112,Pirtobrutinib,BTK inhibitor,Treatment of mantle cell lymphoma,Fatigue, bruising, diarrhea,"Infections, Hemorrhage, Cytopenias"
X112,Nemolizumab,IL-31 receptor A antagonist,Investigational for atopic dermatitis and prurigo nodularis,N/A,N/A
Y112,Lebrikizumab,IL-13 antagonist,Investigational for atopic dermatitis,N/A,N/A
Z112,Tralokinumab,IL-13 antagonist,Treatment of atopic dermatitis,Upper respiratory tract infections, conjunctivitis, injection site reactions,N/A
A113,Bimekizumab,IL-17A and IL-17F antagonist,Treatment of plaque psoriasis,Upper respiratory tract infections, oral candidiasis, injection site reactions,"Suicidal Ideation and Behavior, Increased risk of infections"
B113,Spesolimab,IL-36 receptor antagonist,Treatment of generalized pustular psoriasis (GPP) flares,Infection, injection site reaction,N/A
C113,Mirikizumab,IL-23 antagonist,Treatment of ulcerative colitis,Upper respiratory tract infections, headache, arthralgia,N/A
D113,Risankizumab,IL-23 antagonist,Treatment of psoriasis, Crohn's disease, and psoriatic arthritis,Upper respiratory tract infections, headache, fatigue,N/A
E113,Guselkumab,IL-23 antagonist,Treatment of psoriasis and psoriatic arthritis,Upper respiratory tract infections, headache, injection site reactions,N/A
